prednisone has been researched along with Breast Cancer in 601 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We designed a phase I/II study to evaluate the safety and activity of adding dalteparin and prednisone to metronomic cyclophosphamide and methotrexate in women with measurable metastatic breast cancer (MBC)." | 9.14 | Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growt ( Buckman, RA; Clemons, M; Deboer, GE; Dent, S; Ebos, J; Emmenegger, U; Gardner, S; Kerbel, R; Pritchard, KI; Roche, K; Slingerland, J; Sutherland, DJ; Trudeau, ME; Verma, S; Wong, NS, 2010) |
| "Patients with previously untreated metastatic breast cancer were randomized to receive either paclitaxel 200 mg/m(2) intravenously (IV) over 3 hours for eight cycles (24 weeks) or standard cyclophosphamide 100 mg/m(2)/d orally on days 1 to 14, methotrexate 40 mg/m(2) IV on days 1 and 8, fluorouracil 600 mg/m(2) IV on days 1 and 8, and prednisone 40 mg/m(2)/d orally on days 1 to 14 (CMFP) for six cycles (24 weeks) with epirubicin recommended as second-line therapy." | 9.09 | Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. ( Ackland, S; Bishop, JF; Canetta, R; Dewar, J; Goldstein, D; Gurney, H; Kennedy, I; Levi, J; Olver, IN; Smith, J; Stephenson, J; Tattersall, MH; Toner, GC; Walpole, E, 1999) |
| "When administered as a single agent to previously treated patients with advanced breast cancer, paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) has good activity." | 9.08 | A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand. ( Ackland, S; Bishop, JF; Dewar, J; Goldstein, D; Gurney, H; Kennedy, I; Levi, J; Olver, I; Stephenson, J; Tattersall, MH; Toner, G; Walpole, E, 1997) |
| "CMFVP chemotherapy, either alone or in combination with tamoxifen, has not been shown to be superior to tamoxifen alone in the treatment of postmenopausal women with node-positive, ER-positive, operable breast cancer." | 9.07 | Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. ( Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; Metch, B; Minton, JP; Osborne, CK; Rivkin, SE, 1994) |
| " The amino acid L-arginine can significantly enhance natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity in patients with locally advanced breast cancer." | 9.07 | Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. ( Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, J, 1994) |
| "L-Arginine has been shown, in human breast cancers, to increase protein synthesis and the number of cells in the growth phase of the cell cycle." | 9.07 | Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. ( Ah-See, AK; Brittenden, J; Eremin, O; Gilbert, F; Heys, SD; Hutcheon, AW; McKean, M; Miller, I; Needham, G; Sarkar, TK, 1994) |
| "Sixty-seven patients with advanced breast cancer were prospectively entered into a Phase II trial of cyclophosphamide 100 mg/m2 orally on days 1-14, methotrexate 40 mg/m2 intravenously (i." | 9.07 | A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer. ( Bishop, JF; Dipell, JF; Jeal, P; Laidlaw, CR; Olver, IN; Rischin, D; Zimet, A, 1992) |
| " 5-Fluorouracil, and prednisone (CFP) in patients with advanced breast cancer." | 9.07 | A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer. ( Ahmann, DL; Bisel, HF; Buckner, JC; Ingle, JN; Long, HJ; Rubin, J; Schaid, DJ; Schutt, AJ, 1991) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 9.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for node-positive breast cancer." | 9.06 | Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Fitzgibbons, RG; Foley, JF; Hagen, JB; Ingle, JN; Krook, JE; Martin, JK; Wieand, HS; Wold, LE, 1989) |
| "Four hundred forty-one women with operable breast cancer with histologically positive axillary nodes were randomized to receive either combination cyclophosphamide (60 mg/m2 orally everyday for 1 year); fluorouracil (300 mg/m2 intravenously [IV] weekly for 1 year); methotrexate (15 mg/m2 IV weekly for 1 year); vincristine (0." | 9.06 | Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study. ( Athens, J; Constanzi, JJ; Gad-el-Mawla, N; Glucksberg, H; Green, S; Hoogstraten, B; Maloney, T; Metch, B; Osborne, CK; Rivkin, SE, 1989) |
| "Following mastectomy for node-positive breast cancer, 261 postmenopausal women were randomized to observation or adjuvant treatment with cyclophosphamide, fluorouracil, prednisone (CFP) alone or combined with tamoxifen (T)." | 9.06 | Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; Martin, JK; Paulsen, JK; Twito, DI; Votava, HJ; Wieand, HS; Wold, LE, 1988) |
| "The prospective controlled phase III clinical trial compared the therapeutic value of the cis-platinum - adriamycin - cyclophosphamide combination (CAP) and that of the combination of cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisolone (CMFVP) in untreated metastatic breast cancer." | 9.05 | CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study. ( Cervek, J; Kolarić, K; Roth, A; Vukas, D, 1984) |
| "We assessed the efficacy of a regimen consisting of four cycles of cyclophosphamide, Adriamycin (Adria Laboratories, Inc, Columbus, Ohio), cisplatin (CAP) followed by maintenance with cyclophosphamide, 5-fluorouracil, prednisone (CFP) compared with CFP alone in a randomized trial of 86 patients with advanced breast cancer." | 9.05 | A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer. ( Ahmann, DL; Creagan, ET; Edmonson, JH; Green, SJ; Ingle, JN; Marschke, RF, 1984) |
| "The Southeastern Cancer Study Group, in a prospectively randomized study involving patients with advanced breast cancer, has compared a low dose intermittently administered five-drug regimen including cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) with an aggressively administered three-drug regimen including cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF)." | 9.05 | A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer. ( Bartolucci, A; Carpenter, J; Krauss, S; Lefante, J; Smalley, RV; Vogel, C, 1983) |
| "Fifty-one patients with metastatic breast cancer were randomly allocated to receive either a four drug combination consisting of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or a combination of vincristine, Adriamycin, and cyclophosphamide (VAC) with cross-over on relapse." | 9.05 | Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP). ( Carmo-Pereira, J; Costa, FO; Henriques, E, 1981) |
| "5 mg daily) to an adjuvant cyclophosphamide-methotrexate-5-fluorouracil chemotherapy regimen was investigated in a randomized trial of 505 pre- and perimenopausal patients with operable breast cancer and one to three axillary lymph node metastases (Ludwig Breast Cancer Study I)." | 9.05 | A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. ( , 1985) |
| "After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal status and estrogen-receptor (ER) status and randomized to receive either 12 cycles of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or CMFP plus tamoxifen (CMFPT), or observation alone." | 9.05 | Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. ( Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC, 1985) |
| "A multi-institutional randomized clinical trial was carried out to evaluate the effect of vincristine (V) added to cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) for the treatment of metastatic breast cancer." | 9.05 | An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer. ( Ansfield, FJ; Carter, AC; Escher, GC; Hankey, BF; Segaloff, A; Talley, RW, 1985) |
| "On the basis of this small retrospective survey, we conclude that CMFVP combination chemotherapy is both effective and safe in patients with metastatic breast cancer previously treated with both taxanes and anthracyclines." | 7.78 | Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane. ( Grenader, T, 2012) |
| "Forty-one women with advanced breast cancer were treated with cyclophosphamide, methotrexate, 5-FU, and prednisone." | 7.67 | Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer. ( Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG, 1984) |
| "In this case report the clinical course of a female patient with metastatic breast cancer receiving a mild cytostatic regimen with chlorambucil, methotrexate and prednisone is described." | 7.67 | [Bone marrow necrosis in a patient with metastatic breast cancer in chemotherapy with chlorambucil, methotrexate and prednisone]. ( Voigtmann, R, 1989) |
| " Idarubicin administration, a new daunorubicin analogue (4-demethoxy-daunorubicin), have shown antitumor activity in 23%-31% of previously treated metastatic breast cancer patients, while in untreated patients a response rate of 41% was observed." | 7.67 | Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study. ( Kolarić, K; Mechl, Z; Potrebica, V; Sopkova, B; Vukas, D, 1988) |
| "A four-drug combination of intermittent high-dose cyclophosphamide with 5-fluorouracil, hexamethylmelamine, and prednisone was given to 19 patients with advanced breast cancer." | 7.66 | Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer. ( Chang, YC; Crowley, J; Falkson, G; Tormey, DC, 1981) |
| "Forty-nine postmenopausal patients with advanced breast cancer were treated with a nonsteroidal antiestrogen, Nafoxidine." | 7.66 | Clinical trial of nafoxidine in advanced breast cancer. ( De Jager, RL; Krakoff, IH; Steinbaum, FL, 1978) |
| "Ninety patients with advanced breast cancer received a polychemotherapeutic program composed of 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine as a control group in a series of four consecutive Phase II clinical trials of new drug programs." | 7.65 | An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine. ( Ahmann, DL; Bisel, HF; Eagan, RT; Edmonson, JH; Hahn, RG; Steinfeld, JL; Taylor, WF; Tormey, DC, 1975) |
| "Patients with large primary breast cancers are being treated with neo-adjuvant chemotherapy." | 6.69 | Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. ( Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG, 1998) |
| " They were then assigned at random to receive no further therapy (NT), ovarian irradiation (R) 2000 rads in 5 days, or ovarian irradiation in the same dosage plus prednisone (R + P) 7." | 6.68 | Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Bulbrook, RD; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Hayward, JL; Jenkin, RD; Meakin, JW; Panzarella, T; Pringle, JF; Rider, WD, 1996) |
| "Concerning bone metastases there was no difference between the two schedules in response rate, nor in the median remission duration (CAP 11, FAC 10 months)." | 6.66 | Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study. ( Kolarić, K; Potrebica, V; Vukas, D, 1989) |
| "172 patients who had had mastectomy for breast cancer were treated by repeated adjuvant chemotherapy, either with phenylalanine mustard (P." | 6.64 | Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer. ( Ahmann, DL; Bisel, HF; Edmonson, JH; Frytak, S; Hahn, RG; Ingle, JN; O'Connell, MJ; O'Fallon, JR; Payne, WS; Rubin, J; Scanlon, PW, 1978) |
| "Idiopathic granulomatous mastitis is a rare inflammatory breast disease of unknown etiology." | 5.37 | [Idiopathic granulomatous mastitis treated with steroids and methotrexate]. ( Peña-Santos, G; Ruiz-Moreno, JL, 2011) |
| " We designed a phase I/II study to evaluate the safety and activity of adding dalteparin and prednisone to metronomic cyclophosphamide and methotrexate in women with measurable metastatic breast cancer (MBC)." | 5.14 | Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growt ( Buckman, RA; Clemons, M; Deboer, GE; Dent, S; Ebos, J; Emmenegger, U; Gardner, S; Kerbel, R; Pritchard, KI; Roche, K; Slingerland, J; Sutherland, DJ; Trudeau, ME; Verma, S; Wong, NS, 2010) |
| "Patients with previously untreated metastatic breast cancer were randomized to receive either paclitaxel 200 mg/m(2) intravenously (IV) over 3 hours for eight cycles (24 weeks) or standard cyclophosphamide 100 mg/m(2)/d orally on days 1 to 14, methotrexate 40 mg/m(2) IV on days 1 and 8, fluorouracil 600 mg/m(2) IV on days 1 and 8, and prednisone 40 mg/m(2)/d orally on days 1 to 14 (CMFP) for six cycles (24 weeks) with epirubicin recommended as second-line therapy." | 5.09 | Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. ( Ackland, S; Bishop, JF; Canetta, R; Dewar, J; Goldstein, D; Gurney, H; Kennedy, I; Levi, J; Olver, IN; Smith, J; Stephenson, J; Tattersall, MH; Toner, GC; Walpole, E, 1999) |
| "To compare 1 year of therapy with continuous cyclophosphamide, methotrexate, fluorouracil (5-FU), vincristine, and prednisone (CMFVP) with a short course of treatment with a doxorubicin-based regimen in the postsurgical adjuvant treatment of patients with hormone receptor-negative, node-positive breast cancer." | 5.08 | Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study. ( Abeloff, MD; Budd, GT; Green, S; Hahn, R; Harris, J; Martino, S; O'Bryan, RM; O'Sullivan, J; Rinehart, JJ; Tormey, D, 1995) |
| "When administered as a single agent to previously treated patients with advanced breast cancer, paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) has good activity." | 5.08 | A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand. ( Ackland, S; Bishop, JF; Dewar, J; Goldstein, D; Gurney, H; Kennedy, I; Levi, J; Olver, I; Stephenson, J; Tattersall, MH; Toner, G; Walpole, E, 1997) |
| "One hundred ninety-five women (141 eligible) whose disease was in CR or in CR except for bone metastases following six cycles (6 months) of doxorubicin-containing induction treatment were randomized to receive cyclophosphamide, methotrexate, fluorouracil, prednisone, tamoxifen, and halotestin [CMF(P)TH] or observation." | 5.08 | Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. ( Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D, 1998) |
| "CMFVP chemotherapy, either alone or in combination with tamoxifen, has not been shown to be superior to tamoxifen alone in the treatment of postmenopausal women with node-positive, ER-positive, operable breast cancer." | 5.07 | Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. ( Abeloff, MD; Costanzi, JJ; Cruz, AB; Farrar, WB; Green, S; Jewell, WR; Metch, B; Minton, JP; Osborne, CK; Rivkin, SE, 1994) |
| " The amino acid L-arginine can significantly enhance natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity in patients with locally advanced breast cancer." | 5.07 | Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. ( Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, J, 1994) |
| "L-Arginine has been shown, in human breast cancers, to increase protein synthesis and the number of cells in the growth phase of the cell cycle." | 5.07 | Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. ( Ah-See, AK; Brittenden, J; Eremin, O; Gilbert, F; Heys, SD; Hutcheon, AW; McKean, M; Miller, I; Needham, G; Sarkar, TK, 1994) |
| "To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide, methotrexate, fluorouracil [5-FU], vincristine, and prednisone [CMFVP]) in poor-prognosis breast cancer patients (estrogen receptor [ER]-negative, stage II to IIIA) would result in improved disease-free and overall survival rates." | 5.07 | One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study. ( Altman, SJ; Costanzi, JJ; Green, S; Jewell, WR; Metch, B; Minton, JP; O'Bryan, RM; Osborne, CK; Rivkin, SE, 1993) |
| "Between 1982 and 1986, 319 consecutive patients with stage II or III breast cancer with one or more positive nodes were assigned randomly to receive adjuvant chemotherapy that consisted of escalating doses of doxorubicin and cyclophosphamide in combination with vincristine and prednisone or the same chemotherapy regimen followed by 1 year of leukocyte alpha-interferon." | 5.07 | Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer. ( Ames, FC; Buzdar, AU; Fraschini, G; Gutterman, JU; Holmes, FA; Hortobagyi, GN; Hug, VM; Kau, SW; Singletary, SE; Smith, TL, 1992) |
| "Sixty-seven patients with advanced breast cancer were prospectively entered into a Phase II trial of cyclophosphamide 100 mg/m2 orally on days 1-14, methotrexate 40 mg/m2 intravenously (i." | 5.07 | A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer. ( Bishop, JF; Dipell, JF; Jeal, P; Laidlaw, CR; Olver, IN; Rischin, D; Zimet, A, 1992) |
| "A randomised trial has previously been repeated in which 437 women with node positive breast cancer received either a 12-week chemohormonal regimen consisting of cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, adriamycin and tamoxifen or 36 weeks of CMFVP." | 5.07 | The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation. ( Abu-Zahra, H; Arnold, A; Bramwell, V; Findlay, B; Gent, M; Goodyear, MD; Levine, MN; Skillings, J, 1992) |
| " 5-Fluorouracil, and prednisone (CFP) in patients with advanced breast cancer." | 5.07 | A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer. ( Ahmann, DL; Bisel, HF; Buckner, JC; Ingle, JN; Long, HJ; Rubin, J; Schaid, DJ; Schutt, AJ, 1991) |
| "Two hundred fifty evaluable patients with breast cancer entered a protocol combining neoadjuvant and consolidation therapy by vinblastine (V), thiotepa (T), methotrexate (M), and 5-fluorouracil (F) (VTMF), with or without Adriamycin (A) (doxorubicin; Adria Laboratories, Columbus, OH), and radiation therapy as exclusive locoregional treatment." | 5.06 | Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. ( Auclerc, G; Baillet, F; Borel, C; de Maublanc, MA; Forget, G; Housset, M; Jacquillat, C; Soubrane, C; Thill, L; Weil, M, 1990) |
| "A prospectively controlled randomized trial to compare the adjuvant efficacy of 12 cycles of cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen (CMFPT) followed by observation or a total of 5 years of continuous tamoxifen versus four cycles of CMFPT followed by observation in postmenopausal women with operable node-positive breast cancer was started by the Eastern Cooperative Oncology Group (ECOG) in 1982." | 5.06 | Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. ( Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH, 1990) |
| "A randomized trial has been performed in which women with axillary node-positive breast cancer were allocated to either a short intensive 12-week chemohormonal treatment consisting of cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH), and tamoxifen (CMFVP plus AT) or 36 weeks of CMFVP." | 5.06 | A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer. ( Abu-Zahra, H; Arnold, A; Bramwell, V; DePauw, S; Findlay, B; Gent, M; Hryniuk, WM; Levin, L; Levine, MN; Skillings, J, 1990) |
| " Our earlier study in breast cancer showed that second-line CAP (cyclophosphamide, adriamycin, cis-platinum) treatment was not cross-resistant to the CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) regimen and produced a 51% response rate." | 5.06 | cis-platinum-based alternating non-cross-resistant chemotherapy as a first-line treatment in metastatic breast cancer. A phase II study. ( Kolarić, K; Tomek, R, 1990) |
| "A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for node-positive breast cancer." | 5.06 | Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Fitzgibbons, RG; Foley, JF; Hagen, JB; Ingle, JN; Krook, JE; Martin, JK; Wieand, HS; Wold, LE, 1989) |
| "A randomized trial was performed to determine relative efficacy and toxicity of two first-line combination chemotherapy regimens in women with metastatic breast cancer: CFP (cyclophosphamide, 5-fluorouracil, prednisone) and CMFP (cyclophosphamide, 5-fluorouracil, methotrexate, prednisone)." | 5.06 | Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer. ( Cullinan, SA; Ebbert, LP; Ingle, JN; Krook, JE; Mailliard, JA; Marschke, RF; Pfeifle, DM; Schaid, DJ; Votava, HJ; Windschitl, HE, 1989) |
| "We have evaluated the results of salvage systemic therapy in 257 patients with breast cancer recurrent after surgical adjuvant treatment with cyclophosphamide, fluorouracil, and prednisone (CFP) with or without tamoxifen." | 5.06 | Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer. ( Ahmann, DL; Buckner, JC; Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; O'Fallon, JR; Pfeifle, DM, 1989) |
| "The Eastern Cooperative Oncology Group (ECOG) trial of adjuvant cyclophosphamide, methotrexate, fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen (CMFPT) for 1 year compared with observation alone in 265 postmenopausal patients with node-positive breast cancer is reported with 74 months median follow-up." | 5.06 | Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. ( Carbone, PP; Cummings, FJ; Falkson, G; Gilchrist, KW; Knuiman, MW; Olson, JE; Rosenthal, SN; Sleeper, LA; Taylor, SG; Tormey, DC, 1989) |
| "Four hundred forty-one women with operable breast cancer with histologically positive axillary nodes were randomized to receive either combination cyclophosphamide (60 mg/m2 orally everyday for 1 year); fluorouracil (300 mg/m2 intravenously [IV] weekly for 1 year); methotrexate (15 mg/m2 IV weekly for 1 year); vincristine (0." | 5.06 | Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study. ( Athens, J; Constanzi, JJ; Gad-el-Mawla, N; Glucksberg, H; Green, S; Hoogstraten, B; Maloney, T; Metch, B; Osborne, CK; Rivkin, SE, 1989) |
| "Postmenopausal women who underwent modified radical mastectomy for Stage II, estrogen receptor (ER)-positive breast cancer were randomized to receive endocrine treatment (tamoxifen [T], 40 mg daily for 3 years) alone versus endocrine treatment plus five-drug chemotherapy (Cytoxan [cyclophosphamide, C], methotrexate [M], 5-fluorouracil [F], vincristine [V], and prednisone [P], CMFVP, for 1 year)." | 5.06 | Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer. ( Arafah, BM; Crowe, JP; Gordon, NH; Hubay, CA; Marshall, JS; McGuire, W; Pearson, OH, 1989) |
| "Following mastectomy for node-positive breast cancer, 261 postmenopausal women were randomized to observation or adjuvant treatment with cyclophosphamide, fluorouracil, prednisone (CFP) alone or combined with tamoxifen (T)." | 5.06 | Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer. ( Cullinan, SA; Everson, LK; Ingle, JN; Krook, JE; Martin, JK; Paulsen, JK; Twito, DI; Votava, HJ; Wieand, HS; Wold, LE, 1988) |
| "Three hundred ten patients with Stage II or Stage III breast cancer were entered on an adjuvant protocol consisting of a combination of 5-fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone (FACVP)." | 5.06 | Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. ( Ames, FC; Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, S; Marcus, C; Martin, RG; Smith, TL, 1988) |
| "Eight hundred eighteen premenopausal or perimenopausal breast cancer patients with axillary node metastases were treated with adjuvant chemotherapy (CMF) with or without endocrine treatment (prednisone, oophorectomy) in two concurrent prospective trials." | 5.06 | Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. ( Castiglione, M; Gelber, RD; Goldhirsch, A, 1988) |
| " We performed a randomized trial comparing 12 weeks of chemohormonal therapy (using cyclophosphamide, methotrexate, fluorouracil, vincristine, prednisone, doxorubicin, and tamoxifen) with 36 weeks of chemotherapy (using cyclophosphamide, methotrexate, fluorouracil, vincristine, and prednisone) in patients with Stage II breast cancer." | 5.06 | The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. ( Arnold, A; De Pauw, S; Gent, M; Goodyear, MD; Hirsh, J; Hryniuk, W; Levine, MN, 1988) |
| "Ninety-seven eligible and evaluable women with metastatic breast cancer were placed on a prospective clinical protocol to evaluate the use of continuous cyclic therapy with dibromodulcitol, doxorubicin, vincristine, tamoxifen, and fluoxymesterone (DAVTH) v DAVTH alternating with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP); and the use of pretreatment and serial carcinoembryonic antigen (CEA) levels in these patients." | 5.06 | Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. ( Chang, AY; Davis, TE; Falkson, G; Falkson, HC; Loprinzi, CL; Rasmussen, P; Tormey, DC, 1986) |
| "We have analyzed the relationship between dose intensity of cyclophosphamide, methotrexate, and fluorouracil (CMF)-containing adjuvant chemotherapy of stage II breast cancer and 3-year relapse-free survival." | 5.06 | Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. ( Hryniuk, W; Levine, MN, 1986) |
| "Adjuvant ovarian ablation delays recurrence and prolongs survival in premenopausal patients with breast cancer, but the differences fall short of statistical significance; this effect is enhanced to statistically significant differences by low-dose prednisone." | 5.06 | Review of Canadian trials of adjuvant endocrine therapy for breast cancer. ( Meakin, JW, 1986) |
| "In chemotherapy of advanced breast cancer, the dose intensities of regimens containing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) and cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) correlate with remission rate." | 5.06 | Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer. ( Hryniuk, WM; Levin, L; Levine, MN, 1986) |
| "Many adjuvant chemotherapy regimens used for breast cancer include prednisone, which has the potential to cause hyperglycemia." | 5.06 | Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study. ( Ellis, ME; Korzun, AH; Lesnick, GJ; Norton, L; Perloff, M; Rice, MA; Weiss, RB; Wood, WC, 1986) |
| "Between 1978 and 1981, 463 evaluable postmenopausal patients 65 years of age or younger with operable breast cancer and metastases in axillary lymph nodes were entered in Ludwig Breast Cancer Study III (Ludwig III) and randomly allocated to receive chemoendocrine therapy with cyclophosphamide, methotrexate, 5-fluorouracil, low-dose continuous prednisone, and tamoxifen (CMFp + T) for 12 monthly cycles, or endocrine therapy alone with prednisone and tamoxifen (p + T) for 1 year, or no adjuvant treatment after mastectomy (observation)." | 5.06 | A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. ( Gelber, RD; Goldhirsch, A, 1986) |
| "Adjuvant therapy after total mastectomy and axillary clearance in postmenopausal women with breast cancer and axillary node metastasis was assessed; chemo-endocrine therapy (cyclophosphamide, methotrexate, fluorouracil, prednisone, and tamoxifen; CMFp + T) was compared with endocrine therapy (prednisone and tamoxifen; p + T), and with no adjuvant treatment in 463 patients aged less than or equal to 65 years." | 5.05 | Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis. ( , 1984) |
| "The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone) to two years of intermittent L-phenylalanine mustard (L-PAM) in women with operable breast cancer with histologically positive axillary lymph nodes." | 5.05 | Adjuvant therapy of breast cancer: the Southwest Oncology Group experience. ( Athens, JW; Costanzi, JJ; Foulkes, MA; Glucksberg, H; Knight, WA; O'Bryan, RM; Rivkin, SE; Stephens, RL, 1983) |
| "The prospective controlled phase III clinical trial compared the therapeutic value of the cis-platinum - adriamycin - cyclophosphamide combination (CAP) and that of the combination of cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisolone (CMFVP) in untreated metastatic breast cancer." | 5.05 | CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study. ( Cervek, J; Kolarić, K; Roth, A; Vukas, D, 1984) |
| "We assessed the efficacy of a regimen consisting of four cycles of cyclophosphamide, Adriamycin (Adria Laboratories, Inc, Columbus, Ohio), cisplatin (CAP) followed by maintenance with cyclophosphamide, 5-fluorouracil, prednisone (CFP) compared with CFP alone in a randomized trial of 86 patients with advanced breast cancer." | 5.05 | A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer. ( Ahmann, DL; Creagan, ET; Edmonson, JH; Green, SJ; Ingle, JN; Marschke, RF, 1984) |
| "We report the results of a randomized trial carried out by the Swiss Group for Clinical Cancer Research (SAKK) and in which 230 patients with advanced breast cancer receiving concurrently a hormonal treatment (oophorectomy for pre- and tamoxifen for postmenopausal women) were randomly allocated to three different regimens of combination chemotherapy." | 5.05 | Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer. ( Alberto, P; Brunner, KW; Cavalli, F; Goldhirsch, A; Jungi, WF; Martz, G; Mermillod, B; Pedrazzini, A, 1983) |
| "The Southeastern Cancer Study Group, in a prospectively randomized study involving patients with advanced breast cancer, has compared a low dose intermittently administered five-drug regimen including cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) with an aggressively administered three-drug regimen including cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF)." | 5.05 | A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer. ( Bartolucci, A; Carpenter, J; Krauss, S; Lefante, J; Smalley, RV; Vogel, C, 1983) |
| "Seventy patients with advanced metastatic breast cancer were treated with an oral drug regime of prednisone, cytomel, cytoxan, and methotrexate." | 5.05 | Treatment of breast cancer with oral four-drug chemotherapy. ( Foley, JF; Kessinger, MA; Lemon, HM, 1980) |
| "Fifty-one patients with metastatic breast cancer were randomly allocated to receive either a four drug combination consisting of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or a combination of vincristine, Adriamycin, and cyclophosphamide (VAC) with cross-over on relapse." | 5.05 | Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP). ( Carmo-Pereira, J; Costa, FO; Henriques, E, 1981) |
| "In 1977 we reported our results of an ongoing randomized clinical trial evaluating early or delayed adjuvant chemotherapy utilizing 5-flourouracil, cytoxan and prednisone in premenopausal patients with recurrent or advanced breast cancer." | 5.05 | An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advances breast cancer undergoing oophorectomy: a later analysis. ( Ahmann, DL; Bisel, HF; Edmonson, JH; Green, SJ; Hahn, RG; Ingle, JN; Lee, RA, 1982) |
| "5 mg daily) to an adjuvant cyclophosphamide-methotrexate-5-fluorouracil chemotherapy regimen was investigated in a randomized trial of 505 pre- and perimenopausal patients with operable breast cancer and one to three axillary lymph node metastases (Ludwig Breast Cancer Study I)." | 5.05 | A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. ( , 1985) |
| "After mastectomy, 265 postmenopausal patients with node-positive breast cancer were stratified according to pathologic nodal status and estrogen-receptor (ER) status and randomized to receive either 12 cycles of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP), or CMFP plus tamoxifen (CMFPT), or observation alone." | 5.05 | Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. ( Bennett, JM; Carbone, PP; Cummings, F; Falkson, G; Kalish, LA; Olson, JE; Taylor, SG; Tormey, DC, 1985) |
| "One hundred fifty-five eligible women with metastatic breast cancer were randomly allocated to receive monthly cycles of either CMFP (cyclophosphamide, methotrexate, 5-fluorouracil, prednisone) or CAF (cyclophosphamide, doxorubicin, 5-fluorouracil), and 12 patients were studied to evaluate the effects of additional Corynebacterium parvum immunotherapy." | 5.05 | Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors. ( Cummings, FJ; Gelman, R; Horton, J, 1985) |
| "A multi-institutional randomized clinical trial was carried out to evaluate the effect of vincristine (V) added to cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) for the treatment of metastatic breast cancer." | 5.05 | An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer. ( Ansfield, FJ; Carter, AC; Escher, GC; Hankey, BF; Segaloff, A; Talley, RW, 1985) |
| "Sixty-four patients with disseminated breast cancer were treated with an aggressive chemotherapy program of prednisone, methotrexate, 5-fluorouracil, Adriamycin (doxorubicin) and cyclophosphamide (PM-FAC)." | 5.05 | Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trial. ( Flournoy, N; Livingston, RB; Mortimer, J; Stephens, RL, 1985) |
| "We treated randomly 75 premenopausal patients with advanced breast cancer with combination chemotherapy (5-fluorouracil, cyclophosphamide and prednisone), either as an early adjunct to oophorectomy or as a delayed treatment upon appearance of progressive metastatic disease after operation." | 5.04 | An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy. ( Ahmann, DL; Bisel, HF; Edmonson, JH; Hahn, RG; Lee, RA; O'Connell, MJ, 1977) |
| "A randomized clinical trial, involving approximately 100 patients, that compared two combination therapy regimens (5 FU, methotrexate, vincristine, cyclophosphamide with and without prednisone) in advanced breast cancer showed a significantly higher rate of response for the 5-drug therapy group (62." | 5.04 | Combination chemotherapy in breast cancer: a randomized study of 4 versus 5 drugs. ( Cornell, GN; Klotz, J; Madden, RE; Minton, JP; Ramirez, G; Strawitz, JG; Wilson, WL, 1975) |
| "In patient who develops ibandronate-associated CFSGS, proteinuria appears to be at least partially reversible with the treatment of prednisone and/or tacrolimus if the syndrome is recognized early and ibandronate is stopped." | 4.91 | Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature. ( Cormack, FC; Gralow, JR; Jia, N; Najafian, B; Shiue, Z; Xie, B, 2015) |
| "We reviewed published studies reporting phase II and III clinical trials of dose-dense regimens for breast cancer and NHL, TAC (docetaxel, adriamycin, cyclophosphamide) chemotherapy for breast cancer, and infusional 5-fluorouracil-based regimens for colorectal cancer." | 4.83 | Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. ( Avritscher, EB; Bekele, BN; Cooksley, CD; Elting, LS; Jones, JA; Michelet, M, 2006) |
| "Between 1978 and 1993 the International Breast Cancer Study Group (IBCSG) treated 3700 premenopausal and perimenopausal patients with various timing and duration of adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF with or without low-dose prednisone and oophorectomy)." | 4.80 | Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? ( Aebi, S; Castiglione-Gertsch, M; Coates, AS; Collins, J; Cortes-Funes, H; Crivellari, D; Gelber, RD; Gelber, S; Goldhirsch, A; Lindtner, J; Rudenstam, CM; Simoncini, E; Thürlimann, B; Werner, ID, 2000) |
| " After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias." | 4.78 | Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991) |
| "A 60-year-old woman with cutaneous metastases from heavily pretreated HER2-positive breast cancer received CMFVP (oral cyclophosphamide 100 mg daily; oral prednisone 12." | 3.83 | Response of extensive breast cancer skin metastases to rechallenge with trastuzumab together with low-dose chemotherapy and insulin. ( Calvani, N; Cinieri, S; Fedele, P; Goldhirsch, A; Orlando, L; Schiavone, P, 2016) |
| "Clinical records of patients with pretreated advanced breast cancer and who were treated with the Metronomic-Cooper-type regimen consisting of weekly fixed doses of NPLD (30 mg IV) plus 5-Fluorouracil (5-FU) (500 mg IV) plus vincristine (0." | 3.79 | Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients. ( Ciruelos, E; Cortés-Funes, H; Dorta, M; Ghanem, I; Manneh, R; Manso, L; Mendiola, C; Sepúlveda, J; Valdiviezo, N; Vega, E, 2013) |
| "On the basis of this small retrospective survey, we conclude that CMFVP combination chemotherapy is both effective and safe in patients with metastatic breast cancer previously treated with both taxanes and anthracyclines." | 3.78 | Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane. ( Grenader, T, 2012) |
| "The management of primary breast carcinoma has undergone a successful change during the decade of the 1970s." | 3.75 | Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas. ( DeVita, VT; Henney, JE; Weiss, RB, 1981) |
| "We determined plasma levels of c-erbB-2 in 79 stages II and III breast cancer patients who received cyclophosphamide, methotrexate, and flourouracil (CMF)/cyclophosphamide, methotrexate, fluorouracil, vincristine, and prednisone (CMFVP) chemotherapy." | 3.70 | Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy. ( Das Gupta, TK; Hieken, TJ; Marler, KC; McDermott, JH; Mehta, RR; Patel, MK; Wild, LD, 1998) |
| "Chemotherapy programs using either bolus or infusional delivery were selected representing standard or commonplace regimens for the treatment of patients with breast cancer (cyclophosphamide, methotrexate, fluorouracil [CMF] or CA); colon cancer (5-fluorouracil[5-FU] infusion vs." | 3.69 | Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. ( Anderson, NR; Lokich, JJ; Moore, CL, 1996) |
| "In 56 patients with disseminated or locally advanced breast cancer it was attempted to reach a state of no evidence of disease by a remission induction regime containing prednisone, 5-fluorouracil, methotrexate, doxorubicin and vincristine." | 3.68 | Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer. ( de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; van der Ploeg, E; Willemse, PH, 1993) |
| " This prospective cohort study investigated orofacial complications of combination chemotherapy (cyclophosphamide, methotrexate, fluorouracil, vincristine, and prednisone) in women with breast cancer." | 3.68 | Orofacial complications of chemotherapy for breast cancer. ( McCarthy, GM; Skillings, JR, 1992) |
| "Seventy-five female patients suffering from advanced breast cancer were treated with toilet mastectomy, radiotherapy and oophorectomy (if premenopausal) or tamoxifen therapy (if postmenopausal) as well as chemotherapy with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone." | 3.68 | Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer. ( Dandapat, MC; Mohapatro, SK; Padhi, NC, 1992) |
| "21 patients with metastatic breast cancer, refractory to conventional agents, were treated with a combination of BCNU, vincristine, mitomycin-C and prednisone given every 4 weeks." | 3.67 | Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study. ( Anderson, P; DiBella, NJ; Fink, K; Garfield, D; Murphy, J; Speer, J, 1984) |
| "Twenty-two patients who had metastatic breast cancer previously treated with combination chemotherapy, cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) or CMF with vincristine and prednisone, were treated with Carminomycin (carubicin) 20 mg/m2 body surface area by intravenous bolus injection once every 3 weeks." | 3.67 | Carminomycin. A new anthracycline analog in the treatment of advanced breast cancer. ( Aboud, A; Blumenschein, GR; Bodey, GP; Esparza, L; Hortobagyi, G; Issell, B; Yap, HY, 1984) |
| "Forty-one women with advanced breast cancer were treated with cyclophosphamide, methotrexate, 5-FU, and prednisone." | 3.67 | Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer. ( Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG, 1984) |
| "In this case report the clinical course of a female patient with metastatic breast cancer receiving a mild cytostatic regimen with chlorambucil, methotrexate and prednisone is described." | 3.67 | [Bone marrow necrosis in a patient with metastatic breast cancer in chemotherapy with chlorambucil, methotrexate and prednisone]. ( Voigtmann, R, 1989) |
| "Three hundred thirty-six patients with stage II or stage III breast cancer were treated on an adjuvant protocol containing fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone (FACVP)." | 3.67 | Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma. ( Ang, PT; Buzdar, AU; Hortobagyi, GN; Kau, S; Smith, TL, 1989) |
| " Idarubicin administration, a new daunorubicin analogue (4-demethoxy-daunorubicin), have shown antitumor activity in 23%-31% of previously treated metastatic breast cancer patients, while in untreated patients a response rate of 41% was observed." | 3.67 | Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study. ( Kolarić, K; Mechl, Z; Potrebica, V; Sopkova, B; Vukas, D, 1988) |
| "Seventy patients with poor prognosis, metastatic breast cancer were treated with FUVAC induction chemotherapy (5-fluorouracil, vinblastine, Adriamycin [doxorubicin] and cyclophosphamide)." | 3.67 | Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer. ( Fabian, CJ; Goldberg, RS; Griffin, BR; Hammond, N; Hynes, H; Livingston, RB; Rivkin, SE; Schulman, S; Tranum, BL, 1987) |
| "Thirty cases of fungating breast cancer (stages III and IV) were treated preoperatively by combination chemotherapy using cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, and prednisone." | 3.67 | Preoperative chemotherapy for fungating breast cancer. ( Khanna, NN; Khanna, S; Kumar, A; Shah, LL, 1987) |
| "Clinical and instrumental (ECG, PCG, ultrasonic cardiography and polycardiography) examination of cardiac activity in 98 breast cancer patients treated at the Center after Cooper established the cardiotoxic effect of 5-fluorouracil, vincristine, methotrexate, cyclophosphamide and corticosteroids." | 3.67 | [Cardiotoxic effect of cytostatics in patients with breast cancer]. ( Nekliudova, VI; Seregin, GI; Shkhvatsabaia, LV, 1985) |
| "Described is a patient with early breast carcinoma who developed clinical radiation pneumonitis during primary radiation therapy and concomitant chemotherapy that included prednisone." | 3.67 | Radiation pneumonitis: a complication resulting from combined radiation and chemotherapy for early breast cancer. ( Catane, R; Gez, E; Isacson, R; Sulkes, A; Weshler, Z, 1985) |
| "One hundred and ten patients with stage IV breast cancer were treated with five-drug chemotherapy consisting of prednisone, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine." | 3.66 | Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. ( Manni, A; Pearson, OH; Trujillo, JE, 1980) |
| "Ovarian and adrenal function were studied in premenopausal breast cancer patients before and at intervals during adjuvant therapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF), CMF plus prednisone (CMFP), or CMFP plus tamoxifen (CMFPT)." | 3.66 | Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. ( Davis, TE; Rose, DP, 1980) |
| "A four-drug combination of intermittent high-dose cyclophosphamide with 5-fluorouracil, hexamethylmelamine, and prednisone was given to 19 patients with advanced breast cancer." | 3.66 | Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer. ( Chang, YC; Crowley, J; Falkson, G; Tormey, DC, 1981) |
| "The five-drug combination of fluorouracil imidazole carboxamide dimethyl triazeno, vincristine, bis-chloroethyl nitrosourea, and prednisone (FIVB + P) was given to 120 women with metastatic breast cancer." | 3.66 | A five-drug combination in the treatment of metastatic breast cancer. ( Falkson, G; Falkson, HC, 1981) |
| "A series of 41 patients at the MGH who received 5-drug chemotherapy, cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisone, (CMF VP) as adjuvant to surgical treatment of operable breast cancer with 4 or more positive axillary nodes is compared to an analogous group of patients treated with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) reported by Bonadonna et al." | 3.66 | 5-drug adjuvant chemotherapy for breast cancer. ( Carey, RW; Halpern, E; Kaufman, S; Kelley, RM; Lew, RA; Sohier, WD; Weitzman, SA, 1979) |
| "One hundred women with primary breast cancer with 4 or more metastatic axillary nodes were treated for 9 months postoperatively with vincristine, prednisone, cyclophosphamide, methotrexate, and fluorouracil (VPCMF)." | 3.66 | Adjuvant chemotherapy of breast cancer. ( Cooper, RG; Glidewell, O; Holland, JF, 1979) |
| "Forty-nine postmenopausal patients with advanced breast cancer were treated with a nonsteroidal antiestrogen, Nafoxidine." | 3.66 | Clinical trial of nafoxidine in advanced breast cancer. ( De Jager, RL; Krakoff, IH; Steinbaum, FL, 1978) |
| "Results obtained with a cyclophosphamide, methotrexate, vincristine, 5-FU and prednisone protocol in the treatment of advanced breast cancer are reported." | 3.66 | [Polychemotherapy of advanced cancer of the breast]. ( Mascia, V; Massidda, B; Pellegrini, A, 1978) |
| "Cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone were administered for 165, 28-day cycles to 33 patients with metastatic breast cancer." | 3.65 | Leucovorin in combination chemotherapy of breast cancer. ( Corder, MP; Flannery, EP; Herbst, KD; Justice, GR; Sheets, RF; Stone, WH, 1977) |
| "Ninety patients with advanced breast cancer received a polychemotherapeutic program composed of 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine as a control group in a series of four consecutive Phase II clinical trials of new drug programs." | 3.65 | An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine. ( Ahmann, DL; Bisel, HF; Eagan, RT; Edmonson, JH; Hahn, RG; Steinfeld, JL; Taylor, WF; Tormey, DC, 1975) |
| "Forty patients with metastatic breast cancer who had received no previous cytotoxic therapy were treated with a combination chemotherapy program CMF (P), which included methotrexate, 60 mg/m2, and 5-fluorouracil, 700 mg/m2 intravenously on the first and eighth days, in addition to cyclophosphamide, 100 mg/m2, and prednisone, 40 mg/m2, by mouth daily from the first to the fourteenth day of a 28-day cycle." | 3.65 | Combination chemotherapy for advanced breast cancer: response and effect on survival. ( Canellos, GP; Chabner, BA; DeVita, VT; Gold, GL; Schein, PS; Young, RC, 1976) |
| "Twenty-five patients with advanced metastatic breast cancer were treated with the combination of methotrexate 60 mg/M(2) and 5-fluorouracil 700 mg/M(2) intravenously on the first and eighth days, and cyclophosphamide 100 mg/M(2) and prednisone 40 mg/M(2) by mouth daily for the first 14 days of a 28-day cycle." | 3.65 | Cyclical combination chemotherapy for advanced breast carcinoma. ( Canellos, GP; Chabner, BA; Devita, VT; Gold, GL; Schein, PS; Young, RC, 1974) |
| "To observe the curative effect of Qingjin Runfei Decoction (QRD) combined with hormone and antibiotic in treating radiation pneumonia (RP)." | 2.73 | [Clinical observation on treatment of radiation pneumonia by Qingjin Runfei Decoction combined with hormone and antibiotic]. ( Ma, SL; Yue, JH; Zhang, T, 2007) |
| "Histologic slides from selected breast cancer cases entered on node-negative Eastern Cooperative Oncology Group trials were assigned grades." | 2.70 | Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). ( Allred, DC; Dressler, LG; Gray, R; Hatfield, AK; Martino, S; Page, DL; Robert, NJ; Wood, WC, 2001) |
| "Patients with large primary breast cancers are being treated with neo-adjuvant chemotherapy." | 2.69 | Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. ( Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG, 1998) |
| "The contralateral breast cancer first failure rate at 14 years from surgery was 7." | 2.69 | Analysis of cause-specific failure endpoints using simple proportions: an example from a randomized controlled clinical trial in early breast cancer. ( Meakin, JW; Panzarella, T, 1998) |
| "Women with metastatic breast cancer who had measurable disease, required laboratory tests, had received no prior chemotherapy for metastases, had a Cancer and Leukemia Group B (CALGB) performance status < or = 2, and provided informed consent were eligible." | 2.68 | Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. ( Abrams, J; Aisner, J; Budman, D; Cirrincione, C; Citron, M; Holland, J; Muss, H; Panasci, L; Perloff, M; Perry, M, 1995) |
| " They were then assigned at random to receive no further therapy (NT), ovarian irradiation (R) 2000 rads in 5 days, or ovarian irradiation in the same dosage plus prednisone (R + P) 7." | 2.68 | Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Bulbrook, RD; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Hayward, JL; Jenkin, RD; Meakin, JW; Panzarella, T; Pringle, JF; Rider, WD, 1996) |
| "No fatal complications or chronic pulmonary fibrosis was seen." | 2.68 | Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. ( Chap, L; Glaspy, J; Levine, M; Lill, M; Norton, L; Shpiner, R, 1997) |
| "In 1978 the International (Ludwig) Breast Cancer Study Group (IBCSG) initiated four complementary randomized controlled clinical trials to evaluate the roles of chemo-endocrine combinations or endocrine therapy alone in specific populations defined by risk (for pre- and perimenopausal patients) or by age (for postmenopausal patients)." | 2.67 | The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up. ( Castiglione-Gertsch, M; Collins, J; Cortes-Funes, H; Forbes, J; Gelber, RD; Goldhirsch, A; Hacking, A; Johnsen, C; Lindtner, J; Rudenstam, CM, 1994) |
| "Subsequently 52 patients with stage T4 breast cancer were randomised in a phase III trial to receive either radiotherapy alone (RT) or this chemotherapy and radiotherapy (CHOP + RT)." | 2.67 | Locally advanced breast cancer: report of phase II study and subsequent phase III trial. ( Chetty, U; Hardman, PD; Jack, WJ; Kerr, GR; Leonard, RC; Rodger, A, 1992) |
| "Postoperative women with breast cancer but without histopathological evidence of metastases to the axillary lymph nodes or clinical evidence of metastases were studied." | 2.67 | Chemotherapy versus observation in high-risk node-negative breast cancer patients. ( Cooper, MR; Eudey, L; Falkson, G; Gilchrist, KW; Mansour, EG; Osborne, CK; Shatila, AH; Tormey, DC, 1992) |
| "Concerning bone metastases there was no difference between the two schedules in response rate, nor in the median remission duration (CAP 11, FAC 10 months)." | 2.66 | Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study. ( Kolarić, K; Potrebica, V; Vukas, D, 1989) |
| "Since chemotherapy for metastatic breast cancer is not curative, consideration of the quality of life is important in selecting a treatment regimen." | 2.66 | Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. ( Bishop, JF; Byrne, M; Coates, A; Gebski, V; Gill, G; Harvey, V; Jeal, PN; Snyder, R; Tattersall, MH; Woods, RL, 1987) |
| "The Ludwig Breast Cancer Study Group conducted four concomitant trials involving adjuvant chemotherapy and endocrine therapy." | 2.66 | Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. ( Gelber, R; Goldhirsch, A, 1986) |
| "Treatment results are available (Ludwig Breast Cancer Study Group, Lancet i (1984) 1256-1260)." | 2.66 | Adjuvant treatment in operable breast cancer. ( Goldhirsch, A, 1985) |
| "Women with breast carcinoma and four or more involved ipsilateral axillary lymph nodes were randomly assigned to receive an induction course and 2 yr of maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF, 150 patients), CMF plus vincristine and prednisone (CMFVP, 166 patients), or chemoimmunotherapy with CMF plus the methanol extraction residue of BCG (CMF-MER, 85 patients)." | 2.65 | A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. ( Falkson, G; Falkson, HC; Glidewell, OJ; Henry, PH; Holland, JF; Leone, LA; Perloff, M; Tormey, DC; Weinberg, VE; Weiss, RB, 1983) |
| "Adjuvant therapy trials in breast cancer have grown steadily more complex since 1971, when the first long-term adjuvant trial in the United States was initiated." | 2.65 | Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience. ( Carbone, PP, 1983) |
| " They were then assigned at random to receive no further therapy, ovarian irradiation (2000 rad in five days) or ovarian irradiation in the same dosage plus prednisone, 7." | 2.65 | Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Jenkin, RD; Meakin, JW; Pringle, JF; Reid, JG, 1983) |
| "Fifty cases of advanced breast cancer (stages III and IV) were treated by combination chemotherapy." | 2.65 | High-dose versus low-dose CMFP regimen in advanced breast cancer. ( Khanna, NN; Khanna, S; Kumar, A; Pant, GC, 1984) |
| "Body weight was the only risk factor found to be associated with statistically significant differences in survival." | 2.65 | Body weight and prognosis in breast cancer. ( Boyd, NF; Campbell, JE; Germanson, T; Meakin, JW; Sutherland, DJ; Thomson, DB, 1981) |
| "Since in the treatment of advanced breast cancer chemotherapy and the various hormonal manipulations seem recently to have reached a plateau of effectiveness when used alone, it is widely assumed that the combination of both treatment modalities could improve therapeutic results." | 2.65 | [Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer]. ( Alberto, P; Beer, M; Brunner, KW; Cavalli, F; Jungi, WF; Martz, G; Mermillod, B; Obrecht, JP, 1982) |
| "Patients with advanced breast carcinoma and no prior chemotherapy were prospectively evaluated to assess the induction capabilities of cyclophosphamide, methotrexate and 5-fluorouracil (CMF), Adriamycin and vincristine (AV), and CMF plus prednisone (CMFP)." | 2.65 | Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial. ( Band, PR; DeWys, W; Gelman, R; Perlia, C; Rice, MA; Rosenthal, SN; Sears, M; Tormey, DC, 1982) |
| " They were then assigned at random to receive no further therapy, ovarian irradiation (2000 rads in 5 days) or ovarian irradiation in the same dosage plus prednisone, 7." | 2.65 | Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast. ( Allt, WE; Beale, FA; Brown, TC; Bulbrook, RD; Bush, RS; Clark, RM; Fitzpatrick, PJ; Hawkins, NV; Hayward, JL; Jenkin, RD; Meakin, JW; Pringle, JF; Reid, JG; Rider, WD, 1979) |
| "172 patients who had had mastectomy for breast cancer were treated by repeated adjuvant chemotherapy, either with phenylalanine mustard (P." | 2.64 | Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer. ( Ahmann, DL; Bisel, HF; Edmonson, JH; Frytak, S; Hahn, RG; Ingle, JN; O'Connell, MJ; O'Fallon, JR; Payne, WS; Rubin, J; Scanlon, PW, 1978) |
| "However, since most patients with breast cancer present with local or regional disease but go on to die of disseminated cancer, major improvements in survival are most likely to occur by treating this neoplasm as a systemic disease through cobmining effective local therapy with systemic treatments." | 2.64 | Chemotherapy of disseminated breast cancer. Current status and prospects. ( Band, P; Bauer, M; Carbone, PP; Tormey, D, 1977) |
| "Leukopenia was the dose-limiting toxicity with all three regimens." | 2.64 | Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. ( Bonnet, JD; Braine, H; Costanzi, JJ; George, SL; Hoogstraten, B; Rivkin, SE; Samal, B; Thigpen, T, 1976) |
| "A 39-year-old patient with breast cancer underwent neoadjuvant chemotherapy, radical mastectomy, and radiation therapy." | 2.47 | Palmar fasciitis with polyarthritis syndrome in a patient with breast cancer. ( Hutchins, LF; Kortebein, PM; Krishna, K; Yacoub, A, 2011) |
| "Dermatomyositis is an inflammatory autoimmune condition that has also been associated with malignancy." | 2.47 | Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought. ( Fett, N; Liu, RH, 2011) |
| "We discuss the characteristics of breast cancer that occurs after Hodgkin's lymphoma and also treatment options that could be implemented." | 2.44 | Breast cancer after treatment of Hodgkin's lymphoma: general review. ( Alm El-Din, MA; El-Badawy, SA; Taghian, AG, 2008) |
| "A 47 year old woman with a MALT lymphoma affecting the breast exclusively is reported." | 2.40 | [Primary MALT-type lymphoma of the breast]. ( Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M, 1998) |
| "Metastatic breast cancer continues to take thousands of lives each year despite the advances in screening and adjuvant therapy." | 2.37 | Treatment of advanced breast cancer with chemotherapy. ( Eyre, HJ; Ward, JH, 1988) |
| "The most frequent pathologies were Hodgkin's lymphoma and breast cancer." | 1.62 | Evaluation of ovarian reserve before and after chemotherapy. ( Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F, 2021) |
| "She had distant history of metastatic breast cancer treated with chemotherapy, surgical resection and tamoxifen." | 1.51 | Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement. ( Diamond, T; Kumar, S, 2019) |
| "Chronic eosinophilic pneumonia (CEP) is rare and an idiopathic disorder." | 1.51 | Chronic eosinophilic pneumonia after trastuzumab and radiation therapy for breast cancer: A case report. ( Jin, F; Wang, ST, 2019) |
| "Significant scarring affected all three women." | 1.46 | Pyoderma gangrenosum with pathergy: A potentially significant complication following breast reconstruction. ( Jarrett, P; Locke, M; Patel, DK, 2017) |
| "Patients who survive Hodgkin lymphoma (HL) are at increased risk of secondary neoplasms (SNs)." | 1.43 | Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases. ( Çavdar, A; Ceyhan, K; Deda, H; Gökçora, İH; Gözdaşoğlu, S; Işıkman, E; Pamir, A; Taçyıldız, N; Uluoğlu, Ö; Ünal, E; Yavuz, G, 2016) |
| "Ductal invasive carcinoma and ductal carcinoma in situ represented, respectively, 51 cases (71%) and 14 cases (19%)." | 1.38 | Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. ( Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D, 2012) |
| "Primary breast lymphoma is a rare disease entity." | 1.37 | [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases]. ( Fu, L; Fu, XL; Jin, ZJ; Lang, RG; Liu, FF; Lü, AJ; Wang, XF; Wang, Y; Yang, H, 2011) |
| " Increasing the dosage of oral steroid and minocycline resulted in relief of bullous pemphigoid, although patchy skin pigmentation remained especially in the irradiated skin." | 1.37 | A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. ( Isohashi, F; Koizumi, M; Konishi, K; Tanei, T; Umegaki, N; Yoshioka, Y, 2011) |
| "There were no CNS recurrences in the three patients who received CNS prophylaxis." | 1.37 | Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution. ( Fukuhara, S; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Taniguchi, H; Tanosaki, R; Tobinai, K; Watanabe, T, 2011) |
| "Idiopathic granulomatous mastitis is a rare inflammatory breast disease of unknown etiology." | 1.37 | [Idiopathic granulomatous mastitis treated with steroids and methotrexate]. ( Peña-Santos, G; Ruiz-Moreno, JL, 2011) |
| "Cimetidine-treated RBCs were optimally prepared at room temperature and needed to be tested on the day of preparation." | 1.36 | Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody. ( Arndt, PA; Asuncion, DJ; Brasfield, FM; Garratty, G; Vemuri, SL, 2010) |
| "Considerations were Devic's disease versus metastases." | 1.36 | Breast lymphoma in Sjögren's syndrome complicated by acute monocular blindness. ( Molina, RM; Navarra, SV; Soldevilla, HF, 2010) |
| "This type of breast cancer should be added to a differential diagnosis when a solitary tumor is found in the breast on mammography." | 1.35 | Primary malignant lymphoma of the breast. ( Mizukami, Y; Okumura, H; Takayama, T; Takemura, A; Taniya, T, 2009) |
| "Polymyalgia rheumatica is infrequently the initial manifestation of underlying malignancy." | 1.33 | Polymyalgia rheumatica and breast cancer. ( Gilliland, WR; Keith, MP, 2006) |
| "Twenty-two patients presented with breast cancer (BC) in complete remission after CHOP for NHL." | 1.32 | Breast cancer after curative chemotherapy in non-Hodgkin's lymphoma: examination of the role of drug resistance and retrospective comparison to the outcome of de novo breast cancer. ( Davaris, P; Dimitrakopoulos, A; Kosmas, C; Lazaris, A; Pangalis, GA; Papalambros, E; Rokana, S; Siakantaris, MP; Tsavaris, N; Vadiaka, M; Zorzos, H, 2004) |
| "The incidence of PTS in breast cancer patients treated with a BCNU-containing HDC regimen can be remarkably high." | 1.31 | Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. ( Blume, KG; Cao, TM; Hu, WW; Johnston, LJ; Negrin, RS; Rizk, NW; Shizuru, JA; Stockerl-Goldstein, KE; Taylor, TL; Wong, RM, 2000) |
| "The effect of systemic lupus erythematosus (SLE) treatment drugs on PKC (protein kinase C) activity and cell growth was studied using GI-101A breast tumor cells." | 1.31 | Effect of systemic lupus erythematosus (SLE) treatment drugs on GI-101A breast tumor cell growth. ( Fernandez, Y; Ramakrishnan, R; Rathinavelu, A, 2000) |
| "Transient hypotension was the most common side effect occurring in association with amifostine." | 1.31 | Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. ( Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E, 2001) |
| "The International Breast Cancer Study Group (IBCSG) prospectively explored the efficacy of retreatment for patients upon relapse using the same therapy administered during the adjuvant programme." | 1.30 | Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group. ( Castiglione-Gertsch, M; Coates, A; Collins, J; Gelber, RD; Goldhirsch, A; Gudgeon, A; Hacking, A; Isley, M; Lindtner, J; Rudenstam, CM; Senn, HJ; Tattersall, M, 1997) |
| "Reports of bronchiolitis obliterans organizing pneumonia (BOOP) occurring in women after radiation therapy for breast cancer have suggested that radiation to the lung could participate in the development of BOOP." | 1.30 | Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P) ( Cordier, JF; Crestani, B; Dalphin, JC; Roden, S; Valeyre, D; Wallaert, B, 1998) |
| "A past history of treated Hodgkin disease is a factor of risk for breast cancer and suggests the need for annual mammography screening 10 years after the end of treatment." | 1.29 | [Breast cancer after treatment of Hodgkin's disease]. ( Blanchot, J; Dugast, J; Grall, JY; Le Prise, E; Levêque, J; Meunier, B; Poulain, P, 1995) |
| "Patients with breast cancer and a high number of involved axillary lymph nodes have a poor prognosis, despite adjuvant chemotherapy." | 1.29 | Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes. ( de Graaf, H; de Vries, EG; Dolsma, WV; Mulder, NH; Mulder, PO; Sleijfer, DT; Smit Sibinga, CT; van der Graaf, WT; van der Ploeg, E; Willemse, PH, 1994) |
| "Two patients developed breast cancer 14 and 8 years after treatment of Hodgkin's disease." | 1.29 | Breast cancer developing after therapy for Hodgkin's disease. ( Cascinu, S; Catalano, G; Fedeli, A, 1993) |
| "Aromatase activity was measured in (i) breast cancers by incubating tumour homogenates with [7 alpha 3H]testosterone and characterizing the production of radioactively-labelled oestradiol and (ii) breast fat by incubation of sub-cellular fractions of fibroblast cell lines with [1 beta 3H]androstenedione and monitoring the formation of 3H2O." | 1.29 | Factors influencing aromatase activity in the breast. ( Miller, WR; Mullen, P, 1993) |
| "We present a 69-year-old woman with breast carcinoma who developed a factor VIII inhibitor." | 1.29 | Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancer. ( Cruz, J; Fontcuberta, J; López, A; López, R; Mateo, J; Urrutia, T, 1995) |
| "Stage II patients with breast carcinoma who had undergone lumpectomy." | 1.28 | Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial. ( Allen, S; Bosworth, H; Budman, D; Lehrman, D; Lichtman, SM; Schulman, P; Vinciguerra, V; Weiselberg, L; Weiss, R, 1991) |
| "Weight gain was correlated positively with several psychologic measures but not with assessed biologic measures." | 1.28 | Weight gain with breast cancer adjuvant treatment. ( Carpenter, JT; Levine, EG; Raczynski, JM, 1991) |
| "Arterial thrombosis is also associated with multiagent chemotherapy in patients with breast cancer." | 1.28 | Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. ( Korzun, AH; Norton, L; Perloff, M; Rice, MA; Wall, JG; Weiss, RB; Wood, WC, 1989) |
| "Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated." | 1.28 | [Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989) |
| "Chemotherapy results in metastatic breast cancer reached a plateau: Remission rate and duration are nearly equivalent for several regimens but not equitoxic." | 1.27 | [Vinblastine, 5-fluorouracil and prednisone (VFP) as "second-line" chemotherapy. Contribution to the problem of optimal therapy sequence in metastasizing breast carcinoma]. ( Hartlapp, JH; Illiger, HJ; Peiss, J; Vaupel, HA, 1983) |
| "Nevertheless, because breast cancer is one of the most responsive of the solid tumors to cytotoxic drugs, appropriately chosen chemotherapy can relieve symptoms and prolong survival." | 1.27 | Chemotherapy of advanced breast cancer. A general survey. ( Loeb, V; Lyss, AP, 1984) |
| " Chronic administration of this compound is associated with the development of dose-dependent cardiotoxicity." | 1.27 | [Cytostatic therapy in metastatic breast cancer]. ( Lenzhofer, R; Rainer, H, 1984) |
| "Twenty-three patients with metastatic breast carcinoma were induced with a complex systemic therapy regimen in an attempt to ascertain if a complete remission rate greater than 50% could be obtained with intensive drug exposure." | 1.27 | Short term high density systemic therapy for metastatic breast cancer. ( Carbone, PP; Davis, TE; Kline, JC; Love, RR; Palta, M; Tormey, DC, 1985) |
| "Two patients developed breast cancer after treatment of Hodgkin's disease." | 1.27 | Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. ( Anderson, T; Cox, JD; Gillin, M; Greenberg, M; Janjan, NA; Schewe, K; Wilson, JF, 1988) |
| " Chemotherapy consisted of two cycles of CF (cyclophosphamide at a dosage of 100 mg/m2 orally on days 1-14+5-fluorouracil at 600 mg/m2 iv on days 1 and 8) during concurrent radiotherapy, followed by six cycles of CMFP (same CF dosages+methotrexate at 40 mg/m2 iv on days 1 and 8+prednisone at 40 mg/m2 orally on days 1-14)." | 1.27 | Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update. ( Fowble, BL; Fox, KR; Glick, JH; Glover, DJ; Goodman, RL; Haller, DG; Hurwitz, S; Mackie, JA; Rosato, EF; Weiler, C, 1988) |
| " Since then, a multitude of different combinations and variations in drug dosage and timing have been used." | 1.27 | Adjuvant chemotherapy for breast cancer: 20 years experience using CVFMP chemotherapy. ( Cooper, RG, 1988) |
| "A case of recurrent Hodgkin's disease of the "sarcomatoid" or "syncytial variant" type was seen that occurred as an extension from the mediastinum to a previously uninvolved extranodal site (breast) and pericardium after treatment of classical nodular sclerosing Hodgkin's disease based in the lymph nodes." | 1.27 | Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis. ( Blaustein, JC; Lewkow, L, 1987) |
| "Primary chemotherapy of brain metastases yielded responses in 27 of 52 patients (52%) treated with Cytoxan (cyclophosphamide) (C), 5-fluorouracil (F) and prednisone (P); 19 of 35 (54%) receiving CFP-methotrexate (M) and vincristine (V); 3 of 7 (43%) treated with MVP, and 1 of 6 (17%) receiving Cytoxan plus Adriamycin (doxorubicin) (CA)." | 1.27 | Chemotherapy induces regression of brain metastases in breast carcinoma. ( Lane, WW; Nemoto, T; Rosner, D, 1986) |
| "Neither had evidence of recurrent breast cancer." | 1.27 | Multiple myeloma masquerading as metastatic breast cancer. ( Garrett, TJ; Savage, D, 1986) |
| ", CAF (CPA + ADM + 5-FU), and AC (ADM + CPA) are well known, but the dosage and administration schedule differ somewhat with the researcher." | 1.27 | [Chemotherapy for recurrent breast carcinoma]. ( Taguchi, T, 1985) |
| "The visceral carcinomas (2 breast cancers, 1 carcinoma respectively of the pancreas, the rectum, the liver, the kidneys, the renal pelvis, and the urinary bladder, and one seminoma) were treated by generally accepted surgical principles as far as treatment of the patients was possible." | 1.26 | [Malignant tumors in bearers of kidney grafts in immunosuppressive therapy]. ( Binswanger, U; Briner, J; Largiadèr, F; Uhlschmid, G; Vollenweider, A, 1982) |
| " While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance." | 1.26 | [Results of, and indications for adjuvant chemotherapy in breast cancer]. ( Brunner, KW; Goldhirsch, A; Joss, R; Sonntag, RW; Tschopp, L, 1981) |
| "A choroidal metastasis from a primary breast carcinoma in a 32-year-old woman underwent clinically complete regression during a course of five-drug combined chemotherapy for widespread metastases." | 1.26 | Response of a choroidal metastasis to multiple-drug chemotherapy. ( Brinkley, JR, 1980) |
| "Polychemotherapy of breast cancer was tried years ago, but remained for Cooper to arouse professional interest in multiple-drug therapy." | 1.26 | Management of locally advanced and disseminated breast cancer--chemotherapy. ( Bisel, HF, 1980) |
| "Breast cancer is the most common cause of cancer death in women in this country." | 1.26 | Modern approaches to the treatment of breast cancer. ( Knight, WA; McGuire, WL; Osborne, CK; Yochmowitz, MG, 1980) |
| "Eighty-eight patients with advanced breast cancer were retrospectively reviewed to compare estrogen receptor (ER) data with response to cytotoxic chemotherapy." | 1.26 | Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience. ( Cohen, JL; Marsland, TA; Raam, S; Rosenbaum, C; Stolbach, LL, 1980) |
| "The simultaneous cure of both the intestinal lymphangiectasia and lymphoma with combination chemotherapy suggests new relationships between these conditions as well as new possibilities for the treatment of acquired forms of intestinal lymphangiectasis associated with overwhelming gastrointestinal protein loss." | 1.26 | Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma. ( Bartter, FC; Broder, S; Callihan, TR; DeVita, VT; Jaffe, ES; Strober, W; Waldmann, TA, 1981) |
| "Cases of disintegrating pulmonary metastases are presented." | 1.26 | [Confluent pulmonary deposits from carcinoma of the breast under cytostatic therapy (author's transl)]. ( Blechschmidt, CM; Schermuly, W, 1976) |
| "A group of patients with metastatic breast cancer treated by a distinct drug regimen is analyzed with special respect to clinical and psychological problems." | 1.26 | [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)]. ( Fernholz, HJ; Frik, W; Nüvemann, M, 1976) |
| "Three patients with metastatic breast carcinoma who had untreated locally advanced primary tumors were treated initially with combination chemotherapy followed by hygienic mastectomy." | 1.26 | Mastectomy as an adjunct to combination chemotherapy. ( Aisner, J; Elias, EG; Morris, D; Wiernik, PH, 1978) |
| "91 women with metastatic breast cancer, who received prior CTX-5FU or CTX-5FU-PRD, were treated in 3 consecutive clinical trials with either CTX-5FU-PRD-MTX-VCR, MTX-VCR, or MTX-VCR-PRD in order to elucidate whether the effectiveness of 5 drugs was due only to the newly added drugs (MTX-VCR +/- PRD) or whether the previously used drugs (CTX-5FU) were necessary as potentiating agents." | 1.26 | Potentiating role of previously administered agents in the combination chemotherapy of breast cancer. ( Nemoto, T; Rosner, D; Snyderman, M, 1979) |
| "Dermatomyositis is a disease of unknown etiology characterized by muscle weakness and associated with a variety of cutaneous lesions." | 1.26 | Dermatomyositis and Malignancy. ( Vanderploeg, DE, 1977) |
| "Seventy-two women with metastatic breast cancer were treated with multiple-agent chemotherapy." | 1.26 | Combination chemotherapy in the treatment of advanced breast cancer. ( Dao, TL; Nemoto, T; Rosner, D, 1976) |
| "Although breast cancer presents as localized disease and is treated with local modalities, i." | 1.25 | Chemotherapy in the treatment strategy of breast cancer. ( Carbone, PP, 1975) |
| " Dosage adjustments were often necessary during the initial phases of therapy." | 1.25 | A controlled study in the use of combined drug therapy for metastatic breast cancer. ( Alberto, P; Brunner, KW; Martz, G; Obrecht, P; Senn, HJ; Sonntag, RW, 1975) |
| "Seventeen patients with metastatic breast carcinoma were treated with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisone." | 1.25 | Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinoma. ( Blom, J; Stutz, FH; Tormey, DC, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 390 (64.89) | 18.7374 |
| 1990's | 95 (15.81) | 18.2507 |
| 2000's | 57 (9.48) | 29.6817 |
| 2010's | 53 (8.82) | 24.3611 |
| 2020's | 6 (1.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajabto, W | 1 |
| Angkasa, YK | 1 |
| Harahap, AS | 1 |
| Ham, MF | 1 |
| Brahma, B | 1 |
| Tomita, M | 1 |
| Oura, S | 1 |
| Nishiguchi, H | 1 |
| Makimoto, S | 1 |
| Yuen, C | 1 |
| Soliven, B | 1 |
| Rezania, K | 1 |
| Foo, MY | 1 |
| Lee, WP | 1 |
| Seah, CMJ | 1 |
| Kam, C | 1 |
| Tan, SM | 1 |
| Berjeb, KK | 1 |
| Debbabi, L | 1 |
| Braham, M | 1 |
| Zemni, Z | 1 |
| Chtourou, S | 1 |
| Hannachi, H | 1 |
| Hamdoun, M | 1 |
| Ayadi, M | 1 |
| Kacem, K | 1 |
| Zhioua, F | 1 |
| Fadhlaoui, A | 1 |
| Bahri, O | 1 |
| Chakroun, N | 1 |
| El Khoury, M | 1 |
| Maietta, A | 1 |
| Tran, A | 1 |
| Trop, I | 1 |
| Lalonde, L | 1 |
| Mesurolle, B | 1 |
| Yagmur, Y | 1 |
| Patel, DK | 1 |
| Locke, M | 1 |
| Jarrett, P | 1 |
| Dong, LH | 1 |
| Chen, JL | 1 |
| Gao, X | 2 |
| Li, GP | 1 |
| Li, YF | 1 |
| Song, YP | 1 |
| Wei, XD | 1 |
| Patzelt, M | 1 |
| Zarubova, L | 1 |
| Klener, P | 1 |
| Barta, J | 1 |
| Benkova, K | 1 |
| Brandejsova, A | 1 |
| Trneny, M | 1 |
| Gürlich, R | 1 |
| Sukop, A | 1 |
| Matsuo, T | 1 |
| Tanaka, T | 1 |
| Yano, T | 1 |
| Kumar, S | 1 |
| Diamond, T | 1 |
| Jin, F | 1 |
| Wang, ST | 1 |
| Aviv, A | 1 |
| Tadmor, T | 1 |
| Polliack, A | 3 |
| Binesh, F | 1 |
| Vahedian, H | 1 |
| Akhavan, A | 1 |
| Hakiminia, M | 1 |
| Langeberg, WJ | 1 |
| Siozon, CC | 1 |
| Page, JH | 1 |
| Morrow, PK | 1 |
| Chia, VM | 1 |
| Ouafki, I | 1 |
| Sghiri, T | 1 |
| Lkhoyaali, S | 1 |
| Mrabti, H | 1 |
| Errihani, H | 1 |
| Wei, ZL | 1 |
| Huang, DP | 1 |
| Su, GP | 1 |
| Wang, XH | 1 |
| Jiang, YZ | 1 |
| Huang, LQ | 1 |
| Jia, N | 1 |
| Cormack, FC | 1 |
| Xie, B | 1 |
| Shiue, Z | 1 |
| Najafian, B | 1 |
| Gralow, JR | 1 |
| Yamashita, H | 1 |
| Ueda, Y | 1 |
| Tomita, K | 1 |
| Kitaura, T | 1 |
| Koshobu, T | 1 |
| Suzuki, Y | 1 |
| Shimizu, E | 1 |
| Gözdaşoğlu, S | 1 |
| Pamir, A | 1 |
| Ünal, E | 1 |
| Gökçora, İH | 1 |
| Uluoğlu, Ö | 1 |
| Ceyhan, K | 1 |
| Deda, H | 1 |
| Işıkman, E | 2 |
| Yavuz, G | 1 |
| Taçyıldız, N | 1 |
| Çavdar, A | 1 |
| Sun, X | 1 |
| Xu, B | 1 |
| Li, Y | 1 |
| Du, J | 1 |
| Dong, L | 1 |
| Li, G | 1 |
| Wei, X | 1 |
| Song, Y | 1 |
| Cordier, JF | 2 |
| Cottin, V | 1 |
| Lazor, R | 1 |
| Stoppa-Lyonnet, D | 1 |
| Orlando, L | 1 |
| Schiavone, P | 1 |
| Calvani, N | 1 |
| Fedele, P | 1 |
| Goldhirsch, A | 20 |
| Cinieri, S | 1 |
| Reich, M | 1 |
| Girard, E | 1 |
| Le Rhun, E | 1 |
| Kim, TK | 1 |
| Xu, ML | 1 |
| Podoltsev, NA | 1 |
| Prebet, T | 1 |
| Barbarotta, L | 1 |
| Amin, K | 1 |
| Kasberg, S | 1 |
| Roche, K | 2 |
| Stahl, M | 1 |
| Gore, SD | 1 |
| Zeidan, AM | 1 |
| Ramos-Gallardo, G | 1 |
| Cuenca-Pardo, J | 1 |
| Rodríguez-Olivares, E | 1 |
| Iribarren-Moreno, R | 1 |
| Contreras-Bulnes, L | 1 |
| Vallarta-Rodríguez, A | 1 |
| Kalixto-Sanchez, M | 1 |
| Hernández, C | 1 |
| Ceja-Martinez, R | 1 |
| Torres-Rivero, C | 1 |
| Conway, JL | 1 |
| Connors, JM | 1 |
| Tyldesley, S | 1 |
| Savage, KJ | 1 |
| Campbell, BA | 1 |
| Zheng, YY | 1 |
| Hamm, J | 1 |
| Pickles, T | 1 |
| Zucca, E | 1 |
| Vingerhoedt, NM | 1 |
| Janssen, S | 1 |
| Mravunac, M | 1 |
| Wauters, CA | 1 |
| Strobbe, LJ | 1 |
| Avilés, A | 4 |
| Guo, HY | 1 |
| Zhao, XM | 1 |
| Cao, JN | 1 |
| Hu, XC | 1 |
| Yin, JL | 1 |
| Hong, XN | 1 |
| Li, J | 1 |
| Alm El-Din, MA | 1 |
| El-Badawy, SA | 1 |
| Taghian, AG | 1 |
| Conti, AA | 1 |
| Dilaghi, B | 1 |
| Modesti, PA | 1 |
| Nozzoli, C | 1 |
| Pierce, L | 1 |
| Lewin, A | 1 |
| Abdel-Wahab, M | 1 |
| Elsayyad, N | 1 |
| Zhang, B | 1 |
| Zechmann, CM | 1 |
| Buchheidt, D | 1 |
| Hildenbrand, R | 1 |
| Teubner, J | 1 |
| Takemura, A | 1 |
| Mizukami, Y | 1 |
| Takayama, T | 1 |
| Taniya, T | 1 |
| Okumura, H | 1 |
| Arndt, PA | 1 |
| Garratty, G | 1 |
| Brasfield, FM | 1 |
| Vemuri, SL | 1 |
| Asuncion, DJ | 1 |
| Chlebowski, RT | 1 |
| Wong, NS | 1 |
| Buckman, RA | 1 |
| Clemons, M | 1 |
| Verma, S | 1 |
| Dent, S | 1 |
| Trudeau, ME | 1 |
| Ebos, J | 1 |
| Kerbel, R | 1 |
| Deboer, GE | 1 |
| Sutherland, DJ | 2 |
| Emmenegger, U | 1 |
| Slingerland, J | 1 |
| Gardner, S | 1 |
| Pritchard, KI | 1 |
| Caterson, SA | 1 |
| Nyame, T | 1 |
| Phung, T | 1 |
| Lee, B | 1 |
| Tobias, AM | 1 |
| Soldevilla, HF | 1 |
| Molina, RM | 1 |
| Navarra, SV | 1 |
| Wang, XQ | 1 |
| Zhang, LX | 1 |
| Bi, CF | 1 |
| Luo, TY | 1 |
| Lin, L | 1 |
| Min, M | 1 |
| Zhao, Y | 1 |
| He, GX | 1 |
| Feng, J | 1 |
| Liu, WP | 1 |
| Antoniou, SA | 1 |
| Antoniou, GA | 1 |
| Makridis, C | 1 |
| Spyrou, A | 1 |
| Malkotsi, T | 1 |
| Do, V | 1 |
| Shifrin, DA | 1 |
| Oostendorp, L | 1 |
| Seker, M | 1 |
| Bilici, A | 1 |
| Ustaalioglu, BO | 1 |
| Yilmaz, B | 1 |
| Ozturk, B | 1 |
| Ünal, A | 1 |
| Dane, F | 1 |
| Ozdemir, NY | 1 |
| Elkiran, ET | 1 |
| Kalender, ME | 1 |
| Gumus, M | 1 |
| Benekli, M | 1 |
| Krishna, K | 1 |
| Yacoub, A | 1 |
| Hutchins, LF | 1 |
| Kortebein, PM | 1 |
| Pal, SK | 1 |
| Twardowski, P | 1 |
| Sartor, O | 1 |
| Fett, N | 1 |
| Liu, RH | 1 |
| Neri, N | 3 |
| Nambo, MJ | 3 |
| Yang, H | 1 |
| Lang, RG | 1 |
| Liu, FF | 1 |
| Wang, XF | 1 |
| Jin, ZJ | 1 |
| Lü, AJ | 1 |
| Wang, Y | 1 |
| Fu, XL | 2 |
| Fu, L | 1 |
| Isohashi, F | 1 |
| Konishi, K | 1 |
| Umegaki, N | 1 |
| Tanei, T | 1 |
| Koizumi, M | 1 |
| Yoshioka, Y | 1 |
| Haberer, S | 1 |
| Belin, L | 1 |
| Le Scodan, R | 1 |
| Kirova, YM | 1 |
| Savignoni, A | 1 |
| Stevens, D | 1 |
| Moisson, P | 1 |
| Decaudin, D | 1 |
| Pierga, JY | 1 |
| Reyal, F | 1 |
| Campana, F | 1 |
| Fourquet, A | 1 |
| Bollet, MA | 1 |
| Hawkes, EA | 1 |
| Okines, AF | 1 |
| Plummer, C | 1 |
| Cunningham, D | 1 |
| Sánchez-Nieto, B | 1 |
| Goset, KC | 1 |
| Caviedes, I | 1 |
| Delgado, IO | 1 |
| Córdova, A | 1 |
| Fukuhara, S | 1 |
| Watanabe, T | 1 |
| Munakata, W | 1 |
| Mori, M | 1 |
| Maruyama, D | 1 |
| Kim, SW | 1 |
| Kobayashi, Y | 1 |
| Taniguchi, H | 1 |
| Maeshima, AM | 1 |
| Tanosaki, R | 1 |
| Matsuno, Y | 1 |
| Tobinai, K | 1 |
| Buckman, R | 1 |
| Ghetu, D | 1 |
| Membrez, V | 1 |
| Bregy, A | 1 |
| Vees, HG | 1 |
| Hottelier, D | 1 |
| Girardet, C | 1 |
| Schneider, N | 1 |
| Bieri, S | 1 |
| Yhim, HY | 1 |
| Kim, JS | 1 |
| Kang, HJ | 1 |
| Kim, SJ | 1 |
| Kim, WS | 1 |
| Choi, CW | 1 |
| Eom, HS | 1 |
| Kim, JA | 1 |
| Lee, JH | 1 |
| Won, JH | 1 |
| Shim, H | 1 |
| Huh, J | 1 |
| Lee, DH | 1 |
| Suh, C | 1 |
| Kwak, JY | 1 |
| Müller, S | 1 |
| Eljack, S | 1 |
| DelGaudio, JM | 1 |
| Peña-Santos, G | 1 |
| Ruiz-Moreno, JL | 1 |
| Grenader, T | 1 |
| Osborne, CK | 17 |
| Evens, A | 1 |
| Liewluck, T | 1 |
| Goodman, BP | 1 |
| Milone, M | 1 |
| Onitilo, AA | 1 |
| Govinda, A | 1 |
| Engel, J | 1 |
| Aguiar Bujanda, D | 1 |
| Hernández Sosa, M | 1 |
| Manso, L | 1 |
| Valdiviezo, N | 1 |
| Sepúlveda, J | 1 |
| Ciruelos, E | 1 |
| Mendiola, C | 2 |
| Ghanem, I | 1 |
| Vega, E | 1 |
| Manneh, R | 1 |
| Dorta, M | 1 |
| Cortés-Funes, H | 5 |
| Rivkin, SE | 14 |
| Green, SJ | 4 |
| Lew, D | 1 |
| Costanzi, JJ | 10 |
| Athens, JW | 2 |
| Vaughn, CB | 2 |
| Martino, S | 4 |
| Ustun, C | 1 |
| Dainer, P | 1 |
| Hendricks, L | 1 |
| Bruker, CT | 1 |
| Burgess, R | 1 |
| Weiss, RB | 9 |
| Woolf, SH | 1 |
| Demakos, E | 1 |
| Holland, JF | 11 |
| Berry, DA | 1 |
| Falkson, G | 17 |
| Cirrincione, CT | 1 |
| Robbins, A | 1 |
| Bothun, S | 1 |
| Henderson, IC | 2 |
| Norton, L | 6 |
| Longo, DL | 1 |
| Kraemer, DM | 1 |
| Weissinger, F | 1 |
| Reimer, P | 1 |
| Kunzmann, V | 1 |
| Rüdiger, T | 1 |
| Wilhelm, M | 1 |
| Gholam, D | 1 |
| Bibeau, F | 2 |
| El Weshi, A | 2 |
| Bosq, J | 1 |
| Ribrag, V | 2 |
| MOESCHLIN, S | 2 |
| THALMANN, A | 2 |
| SIGWALD, J | 1 |
| DE AJURIAGUERRA, J | 1 |
| BOUTTIER, D | 1 |
| BRINKLEY, DM | 1 |
| PILLERS, EK | 1 |
| ELEY, A | 1 |
| RIDDELL, V | 1 |
| GARDNER, B | 5 |
| GORDAN, GS | 4 |
| LOKEN, HF | 2 |
| THOMAS, AN | 3 |
| LANGNICKEL, D | 1 |
| JANTET, G | 1 |
| CROCKER, DW | 1 |
| SHIRAKI, M | 1 |
| MOORE, FD | 3 |
| JADRESIC, A | 1 |
| PABST, I | 1 |
| LAZO, M | 1 |
| SCHOYER, NH | 1 |
| WITT, JA | 1 |
| GRAHAM, WP | 3 |
| SUNDMARK, E | 1 |
| STUDER, H | 1 |
| LEHMANN, U | 1 |
| TEAL, JS | 1 |
| MARTZ, G | 9 |
| MCGOVERN, EL | 1 |
| PERRIN, WE | 1 |
| LEMON, HM | 2 |
| PARSONS, L | 1 |
| MOZDEN, PH | 1 |
| WILLAMO, HH | 2 |
| CONKLIN, EF | 1 |
| NISSEN-MEYER, R | 4 |
| DEDERICK, MM | 1 |
| TAFT, PD | 1 |
| LOJANANOND, P | 1 |
| HALL, TC | 2 |
| KARNOFSKY, DA | 1 |
| BURGER, HG | 1 |
| KENT, JR | 1 |
| KELLIE, AE | 1 |
| FRENKEL, M | 1 |
| SCHWARZ, F | 1 |
| KUIPERS, T | 1 |
| LOKKERBOL, H | 1 |
| HOUTZAGERS, JJ | 1 |
| GREENSPAN, EM | 1 |
| GOLDMAN, BS | 1 |
| PEARSON, FG | 1 |
| MANNHEIMER, IH | 1 |
| STRATFORD, EC | 1 |
| TANAKA, KR | 1 |
| Nagasaki, E | 1 |
| Furuta, N | 1 |
| Shinozaki, E | 1 |
| Tokutome, N | 1 |
| Mishima, Y | 1 |
| Chin, K | 1 |
| Terui, Y | 1 |
| Mizunuma, N | 1 |
| Takahashi, S | 1 |
| Itoh, Y | 1 |
| Usui, N | 1 |
| Hatake, K | 1 |
| Crivellari, D | 2 |
| Price, K | 1 |
| Gelber, RD | 14 |
| Castiglione-Gertsch, M | 6 |
| Rudenstam, CM | 7 |
| Lindtner, J | 7 |
| Fey, MF | 1 |
| Senn, HJ | 12 |
| Coates, AS | 4 |
| Collins, J | 6 |
| Tsavaris, N | 1 |
| Kosmas, C | 1 |
| Zorzos, H | 1 |
| Lazaris, A | 1 |
| Vadiaka, M | 1 |
| Dimitrakopoulos, A | 1 |
| Siakantaris, MP | 1 |
| Rokana, S | 1 |
| Papalambros, E | 1 |
| Pangalis, GA | 1 |
| Davaris, P | 1 |
| Gruber, G | 1 |
| Greiner, RH | 1 |
| Hlushchuk, R | 1 |
| Aebersold, DM | 1 |
| Altermatt, HJ | 1 |
| Berclaz, G | 1 |
| Djonov, V | 1 |
| Huang, DZ | 1 |
| He, XH | 1 |
| Yang, S | 1 |
| Shi, YK | 1 |
| Pruthi, S | 1 |
| Stafyla, VK | 1 |
| Phillips, SW | 1 |
| Porrata, LF | 1 |
| Reynolds, CA | 1 |
| Pestalozzi, BC | 1 |
| Knuth, A | 1 |
| Wang, JC | 1 |
| Shi, DR | 1 |
| Lu, CL | 1 |
| Lu, WP | 1 |
| Uesato, M | 1 |
| Miyazawa, Y | 1 |
| Gunji, Y | 1 |
| Ochiai, T | 1 |
| Vardar, E | 1 |
| Ozkok, G | 1 |
| Cetinel, M | 1 |
| Postaci, H | 1 |
| Ogawa, T | 1 |
| Mizutani, M | 1 |
| Yabana, T | 1 |
| Miyahara, S | 1 |
| Murabayashi, K | 1 |
| Delgado, S | 1 |
| Murillo, E | 1 |
| Cleto, S | 2 |
| Choo, SP | 1 |
| Lim, ST | 1 |
| Wong, EH | 1 |
| Tao, M | 1 |
| Jones, JA | 1 |
| Avritscher, EB | 1 |
| Cooksley, CD | 1 |
| Michelet, M | 1 |
| Bekele, BN | 1 |
| Elting, LS | 1 |
| Keith, MP | 1 |
| Gilliland, WR | 1 |
| Tolaney, SM | 1 |
| Partridge, AH | 1 |
| Sheib, RG | 1 |
| Burstein, HJ | 1 |
| Winer, EP | 2 |
| Mansuet-Lupo, A | 1 |
| de Roquancourt, A | 1 |
| Brière, J | 1 |
| Espié, M | 1 |
| Janin, A | 1 |
| Cao, YB | 1 |
| Wang, SS | 1 |
| Huang, HQ | 1 |
| Xu, GC | 1 |
| He, YJ | 1 |
| Guan, ZZ | 1 |
| Lin, TY | 1 |
| Zhang, T | 1 |
| Ma, SL | 1 |
| Yue, JH | 1 |
| Castañeda, C | 1 |
| Bissoli, L | 1 |
| Di Francesco, V | 1 |
| Valbusa, F | 1 |
| Zivelonghi, A | 1 |
| Fantin, F | 1 |
| Zamboni, M | 1 |
| Stasi, R | 1 |
| Evangelista, ML | 1 |
| Brunetti, M | 1 |
| Bussa, S | 1 |
| Maritati, R | 1 |
| Turrini, L | 1 |
| Taccogna, S | 1 |
| Crescenzi, A | 1 |
| Angelini, F | 1 |
| Moure, JM | 1 |
| Ezrin, C | 1 |
| Briant, TD | 1 |
| Firestone, G | 1 |
| Rosen, F | 1 |
| Muirhead, W | 1 |
| Alessandroni, M | 1 |
| Silber, JH | 1 |
| Manni, A | 2 |
| Trujillo, JE | 1 |
| Pearson, OH | 3 |
| Moser, K | 1 |
| Pohl, A | 1 |
| Böttcher, HD | 1 |
| Pötter, R | 1 |
| Schütz, J | 1 |
| Loprinzi, CL | 4 |
| Carbone, PP | 9 |
| Tormey, DC | 23 |
| Rosenbaum, PR | 1 |
| Caldwell, W | 1 |
| Kline, JC | 2 |
| Steeves, RA | 1 |
| Ramirez, G | 5 |
| Schönfelder, M | 1 |
| Nixon, DW | 1 |
| Shlaer, SM | 1 |
| Stephens, RB | 1 |
| Abeloff, MD | 7 |
| Mellits, ED | 1 |
| Baker, RR | 2 |
| Pezner, RD | 1 |
| Bertrand, M | 1 |
| Cecchi, GR | 1 |
| Paladugu, RR | 1 |
| Kendregan, BA | 1 |
| Tormey, D | 4 |
| Gelman, R | 4 |
| Gundersen, S | 1 |
| Kvaløy, S | 1 |
| Fosså, SD | 3 |
| Høst, H | 1 |
| Weinberg, VE | 3 |
| Glidewell, OJ | 3 |
| Perloff, M | 8 |
| Falkson, HC | 5 |
| Henry, PH | 2 |
| Leone, LA | 3 |
| Illiger, HJ | 1 |
| Peiss, J | 1 |
| Vaupel, HA | 1 |
| Hartlapp, JH | 1 |
| Wood, WC | 6 |
| Knight, WA | 4 |
| Glucksberg, H | 5 |
| Foulkes, MA | 1 |
| Stephens, RL | 3 |
| O'Bryan, RM | 3 |
| Meakin, JW | 10 |
| Allt, WE | 5 |
| Beale, FA | 5 |
| Bush, RS | 5 |
| Clark, RM | 5 |
| Fitzpatrick, PJ | 5 |
| Hawkins, NV | 5 |
| Jenkin, RD | 5 |
| Pringle, JF | 5 |
| Reid, JG | 4 |
| Kumar, A | 2 |
| Khanna, NN | 2 |
| Pant, GC | 1 |
| Khanna, S | 2 |
| Kennedy, BJ | 2 |
| Cortes, E | 1 |
| Silver, RT | 3 |
| Aisner, J | 4 |
| Kolarić, K | 4 |
| Roth, A | 1 |
| Vukas, D | 3 |
| Cervek, J | 1 |
| Creagan, ET | 2 |
| Ahmann, DL | 14 |
| Ingle, JN | 15 |
| Edmonson, JH | 7 |
| Marschke, RF | 4 |
| Hryniuk, W | 3 |
| Bush, H | 1 |
| Hubay, CA | 2 |
| Arafah, B | 1 |
| Gordon, NH | 2 |
| Guyton, SP | 1 |
| Crowe, JP | 2 |
| Sledge, GW | 2 |
| Taylor, SG | 5 |
| Gray, R | 9 |
| Olson, JE | 4 |
| Jones, SE | 2 |
| Moon, TE | 2 |
| Tormey, C | 1 |
| Foulkes, M | 4 |
| Rossi, A | 4 |
| Brambilla, C | 4 |
| Valagussa, P | 6 |
| Bonadonna, G | 6 |
| Danoff, BF | 1 |
| Goodman, RL | 2 |
| Glick, JH | 3 |
| Haller, DG | 2 |
| Pajak, TF | 1 |
| DiBella, NJ | 1 |
| Garfield, D | 1 |
| Fink, K | 1 |
| Anderson, P | 1 |
| Speer, J | 1 |
| Murphy, J | 1 |
| Rose, DP | 1 |
| Davis, TE | 3 |
| Renner, H | 1 |
| Lang, C | 1 |
| Ziegler, K | 1 |
| Aboud, A | 1 |
| Yap, HY | 2 |
| Esparza, L | 1 |
| Blumenschein, GR | 3 |
| Hortobagyi, G | 3 |
| Issell, B | 1 |
| Bodey, GP | 1 |
| Lyss, AP | 1 |
| Loeb, V | 1 |
| Waxman, M | 1 |
| Fatteh, S | 1 |
| Elias, JM | 1 |
| Vuletin, JC | 1 |
| Pinnamaneni, K | 1 |
| Buzdar, AU | 9 |
| Distefano, A | 1 |
| Cadman, EC | 1 |
| Cross, J | 1 |
| Horton, J | 4 |
| Goodnough, LT | 1 |
| Saito, H | 1 |
| Jones, PK | 1 |
| Rainer, H | 1 |
| Lenzhofer, R | 1 |
| Soffer, T | 1 |
| Chan, WC | 1 |
| Brynes, RK | 1 |
| Vogler, WR | 1 |
| O'Neal, S | 1 |
| Smalley, RV | 5 |
| Bartolucci, AA | 3 |
| Moore, M | 1 |
| Vogel, C | 3 |
| Carpenter, J | 4 |
| Perez, CA | 1 |
| Velez-Garcia, E | 2 |
| Marcial, V | 1 |
| Lefante, J | 2 |
| Wittliff, J | 1 |
| Waibel, PJ | 1 |
| Jungi, WF | 6 |
| Cavalli, F | 5 |
| Pedrazzini, A | 1 |
| Brunner, KW | 10 |
| Mermillod, B | 2 |
| Alberto, P | 6 |
| Hirshaut, Y | 1 |
| Kesselheim, H | 1 |
| Levitt, SH | 1 |
| Khan, FM | 1 |
| Boen, JR | 1 |
| Potish, RA | 1 |
| Bowers, BJ | 1 |
| Bartolucci, A | 2 |
| Krauss, S | 2 |
| Trishkina, EA | 1 |
| Gershanovich, ML | 1 |
| Pavlov, KA | 1 |
| Danova, LA | 1 |
| Labkovskiĭ, BM | 1 |
| Chang, YC | 1 |
| Crowley, J | 1 |
| Peetz, ME | 1 |
| Nunley, DL | 1 |
| Moseley, HS | 1 |
| Keenan, EJ | 1 |
| Davenport, CE | 1 |
| Fletcher, WS | 1 |
| Maniscalco-Greb, E | 1 |
| Lockhard, C | 1 |
| Groshko, G | 1 |
| Enochs, K | 1 |
| Duffin, H | 1 |
| Demitrish, M | 1 |
| Carbone, A | 1 |
| Volpe, R | 1 |
| Tirelli, U | 1 |
| Veronesi, A | 1 |
| Galligioni, E | 2 |
| Trovo, MG | 1 |
| Grigoletto, E | 1 |
| Pérez, JE | 2 |
| Machiavelli, M | 1 |
| Romero, A | 2 |
| Leone, BA | 3 |
| Rabinovich, MG | 3 |
| Arévalo, E | 1 |
| Boyd, NF | 3 |
| Campbell, JE | 1 |
| Germanson, T | 1 |
| Thomson, DB | 1 |
| Foley, JF | 2 |
| Kessinger, MA | 1 |
| Henney, JE | 1 |
| DeVita, VT | 6 |
| Nisker, JA | 1 |
| Siiteri, PK | 1 |
| Carmo-Pereira, J | 5 |
| Costa, FO | 5 |
| Henriques, E | 5 |
| Cowan, K | 1 |
| Lippman, M | 1 |
| Jungi, F | 1 |
| Brunner, K | 1 |
| Rozencweig, M | 1 |
| Von Hoff, DD | 1 |
| Allegra, JC | 2 |
| Muggia, FM | 2 |
| Rider, WD | 4 |
| Hayward, JL | 3 |
| Bulbrook, RD | 3 |
| Holland, F | 1 |
| Lesnick, G | 1 |
| Tranum, BL | 2 |
| McDonald, B | 1 |
| Thigpen, T | 2 |
| Vaughn, C | 2 |
| Wilson, H | 1 |
| Maloney, T | 3 |
| Costanzi, J | 2 |
| Bickers, J | 1 |
| el Mawli, NG | 1 |
| Palmer, R | 1 |
| Hoogstraten, B | 4 |
| Heilburn, L | 1 |
| Rasmusen, S | 1 |
| Vollenweider, A | 1 |
| Largiadèr, F | 1 |
| Uhlschmid, G | 1 |
| Binswanger, U | 1 |
| Briner, J | 1 |
| Cohen, E | 1 |
| Scanlon, EF | 1 |
| Caprini, JA | 1 |
| Cunningham, MP | 1 |
| Oviedo, MA | 1 |
| Robinson, B | 1 |
| Knox, KL | 1 |
| Heuson, JC | 1 |
| Paridaens, R | 1 |
| Rasmussen, S | 1 |
| Tranum, B | 1 |
| Gad-el-Mawla, N | 3 |
| Athens, J | 2 |
| McCracken, J | 1 |
| Beer, M | 1 |
| Obrecht, JP | 2 |
| Band, PR | 1 |
| Sears, M | 1 |
| Rosenthal, SN | 2 |
| DeWys, W | 1 |
| Perlia, C | 1 |
| Rice, MA | 3 |
| Bisel, HF | 11 |
| Hahn, RG | 8 |
| Lee, RA | 2 |
| O'Fallon, JR | 4 |
| Scanlon, PW | 2 |
| Payne, WS | 2 |
| Frytak, S | 3 |
| Rubin, J | 4 |
| Nemoto, T | 7 |
| Simon, R | 2 |
| Dao, TL | 2 |
| Rosner, D | 7 |
| Cunningham, T | 2 |
| Sponzo, R | 2 |
| Snyderman, M | 2 |
| Friedman, MA | 1 |
| Marcus, F | 1 |
| Kohler, M | 1 |
| Resser, KJ | 1 |
| von Rottkay, P | 1 |
| Lössl, HJ | 1 |
| Telhaug, R | 1 |
| Lund, G | 1 |
| Børmer, O | 1 |
| Landó, O | 1 |
| Joss, R | 2 |
| Sonntag, RW | 3 |
| Tschopp, L | 1 |
| Dorociak, R | 1 |
| Brinkley, JR | 1 |
| Bitran, JD | 1 |
| Bekerman, C | 1 |
| Desser, RK | 1 |
| Glidewell, O | 2 |
| Cooper, RG | 4 |
| Yochmowitz, MG | 1 |
| McGuire, WL | 1 |
| Rosenbaum, C | 1 |
| Marsland, TA | 1 |
| Stolbach, LL | 1 |
| Raam, S | 1 |
| Cohen, JL | 1 |
| Broder, S | 1 |
| Callihan, TR | 1 |
| Jaffe, ES | 1 |
| Strober, W | 1 |
| Bartter, FC | 1 |
| Waldmann, TA | 1 |
| Elledge, RM | 1 |
| Mansour, E | 1 |
| Yu, Y | 1 |
| Clark, GM | 1 |
| Ravdin, P | 1 |
| Gilchrist, K | 3 |
| Davidson, NE | 1 |
| Robert, N | 1 |
| Tarella, C | 1 |
| Boccadoro, M | 1 |
| Omedé, P | 1 |
| Bondesan, P | 1 |
| Caracciolo, D | 1 |
| Frieri, R | 1 |
| Bregni, M | 1 |
| Siena, S | 1 |
| Gianni, AM | 1 |
| Pileri, A | 1 |
| Budd, GT | 1 |
| Green, S | 7 |
| Rinehart, JJ | 1 |
| Hahn, R | 1 |
| Harris, J | 2 |
| O'Sullivan, J | 3 |
| Levêque, J | 1 |
| Meunier, B | 1 |
| Poulain, P | 1 |
| Blanchot, J | 1 |
| Dugast, J | 1 |
| Le Prise, E | 1 |
| Grall, JY | 1 |
| Cirrincione, C | 1 |
| Perry, M | 2 |
| Budman, D | 2 |
| Abrams, J | 1 |
| Panasci, L | 1 |
| Muss, H | 1 |
| Citron, M | 1 |
| Holland, J | 1 |
| Johnsen, C | 1 |
| Hacking, A | 3 |
| Forbes, J | 1 |
| Kalaycioglu, M | 1 |
| Kavuru, M | 1 |
| Tuason, L | 1 |
| Bolwell, B | 1 |
| Hainsworth, JD | 1 |
| Price, KN | 2 |
| Castiglione, M | 4 |
| Marini, G | 2 |
| Spitzer, G | 2 |
| Dunphy, FR | 1 |
| Petruska, PJ | 1 |
| Velasquez, WS | 1 |
| Adkins, DR | 1 |
| Metch, B | 3 |
| Cruz, AB | 2 |
| Jewell, WR | 3 |
| Farrar, WB | 2 |
| Minton, JP | 3 |
| Brittenden, J | 2 |
| Heys, SD | 3 |
| Ross, J | 1 |
| Park, KG | 1 |
| Eremin, O | 3 |
| de Graaf, H | 1 |
| Willemse, PH | 2 |
| de Vries, EG | 2 |
| Sleijfer, DT | 2 |
| Mulder, PO | 2 |
| van der Graaf, WT | 1 |
| Smit Sibinga, CT | 1 |
| van der Ploeg, E | 2 |
| Dolsma, WV | 2 |
| Mulder, NH | 2 |
| Miller, I | 2 |
| Sarkar, TK | 1 |
| Hutcheon, AW | 2 |
| Needham, G | 1 |
| Gilbert, F | 1 |
| McKean, M | 1 |
| Ah-See, AK | 2 |
| Ras, E | 1 |
| Michaeli, J | 1 |
| Rosenmann, E | 1 |
| Popovtzer, MM | 1 |
| Shouval, D | 1 |
| Cohen, Y | 2 |
| Goldenberg, N | 1 |
| Kasis, S | 1 |
| Shpilberg, D | 1 |
| Oren, M | 1 |
| Glantz, MJ | 1 |
| Biran, H | 1 |
| Myers, ME | 1 |
| Gockerman, JP | 1 |
| Friedberg, MH | 1 |
| Altman, SJ | 1 |
| Cascinu, S | 1 |
| Fedeli, A | 1 |
| Catalano, G | 1 |
| Miller, WR | 1 |
| Mullen, P | 1 |
| Bhardwaj, S | 2 |
| A'Hern, RP | 1 |
| Smith, IE | 1 |
| Ebbs, SR | 1 |
| López, R | 1 |
| Mateo, J | 1 |
| Cruz, J | 1 |
| López, A | 1 |
| Urrutia, T | 1 |
| Fontcuberta, J | 1 |
| Korzun, AH | 3 |
| Carey, RW | 3 |
| Gottlieb, A | 1 |
| Aust, JC | 1 |
| Bank, A | 1 |
| Saleh, F | 1 |
| Canellos, GP | 4 |
| Perry, MC | 1 |
| Lokich, JJ | 3 |
| Moore, CL | 2 |
| Anderson, NR | 2 |
| Murray, S | 2 |
| Tattersall, MH | 4 |
| Gudgeon, A | 2 |
| Forbes, JF | 1 |
| Panzarella, T | 3 |
| Uthman, I | 1 |
| Vázquez-Abad, D | 1 |
| Senécal, JL | 1 |
| Body, JJ | 1 |
| Hering, M | 1 |
| Hagel, E | 1 |
| Zwicker, C | 1 |
| Krieger, G | 1 |
| Sauer, R | 1 |
| Martus, P | 1 |
| Zhan, Z | 1 |
| Sandor, VA | 1 |
| Gamelin, E | 1 |
| Regis, J | 1 |
| Dickstein, B | 1 |
| Wilson, W | 1 |
| Fojo, AT | 1 |
| Bates, SE | 1 |
| Bishop, JF | 5 |
| Dewar, J | 3 |
| Toner, G | 1 |
| Olver, I | 1 |
| Ackland, S | 2 |
| Kennedy, I | 2 |
| Goldstein, D | 2 |
| Gurney, H | 2 |
| Walpole, E | 2 |
| Levi, J | 2 |
| Stephenson, J | 2 |
| Cameron, DA | 1 |
| Anderson, ED | 1 |
| Levack, P | 1 |
| Hawkins, RA | 1 |
| Anderson, TJ | 1 |
| Leonard, RC | 2 |
| Forrest, AP | 1 |
| Chetty, U | 2 |
| Ogston, K | 1 |
| Walker, LG | 1 |
| Sarker, TK | 1 |
| Chap, L | 1 |
| Shpiner, R | 1 |
| Levine, M | 1 |
| Lill, M | 1 |
| Glaspy, J | 1 |
| Gelman, RS | 3 |
| Pandya, KJ | 1 |
| Cummings, FJ | 5 |
| Tattersall, M | 1 |
| Coates, A | 2 |
| Isley, M | 1 |
| Lands, RH | 1 |
| Mehta, RR | 1 |
| McDermott, JH | 1 |
| Hieken, TJ | 1 |
| Marler, KC | 1 |
| Patel, MK | 1 |
| Wild, LD | 1 |
| Das Gupta, TK | 1 |
| Airoldi, M | 1 |
| Pecchio, F | 1 |
| Albanese, F | 1 |
| Mastromatteo, V | 1 |
| Gariboldi, A | 1 |
| Negri, L | 1 |
| Fazio, M | 1 |
| Rafel, M | 1 |
| Esteve, J | 1 |
| Cervantes, F | 1 |
| Velasco, M | 1 |
| Serra, A | 1 |
| Campo, E | 1 |
| Montserrat, E | 1 |
| Fossati, R | 1 |
| Confalonieri, C | 1 |
| Torri, V | 1 |
| Ghislandi, E | 1 |
| Penna, A | 1 |
| Pistotti, V | 1 |
| Tinazzi, A | 1 |
| Liberati, A | 1 |
| Pinder, SE | 1 |
| Ellis, IO | 1 |
| Trihia, H | 1 |
| Elston, CW | 1 |
| Simoncini, E | 2 |
| Byrne, MJ | 1 |
| Golouh, R | 1 |
| Gusterson, BA | 1 |
| Mansour, EG | 3 |
| Shatila, AH | 3 |
| Cooper, MR | 6 |
| Crestani, B | 1 |
| Valeyre, D | 1 |
| Roden, S | 1 |
| Wallaert, B | 1 |
| Dalphin, JC | 1 |
| Ampil, FL | 1 |
| Ataga, KI | 1 |
| Graham, ML | 1 |
| Evans, HN | 1 |
| Braeuning, P | 1 |
| Orringer, EP | 1 |
| Kuper-Hommel, MJ | 1 |
| Vrints, LW | 1 |
| Coebergh, JW | 1 |
| Vreugdenhil, G | 1 |
| Toner, GC | 1 |
| Smith, J | 1 |
| Olver, IN | 2 |
| Canetta, R | 1 |
| Bhalla, KS | 1 |
| Wilczynski, SW | 1 |
| Abushamaa, AM | 1 |
| Petros, WP | 1 |
| McDonald, CS | 1 |
| Loftis, JS | 1 |
| Chao, NJ | 1 |
| Vredenburgh, JJ | 1 |
| Folz, RJ | 1 |
| Ferraresi, V | 1 |
| Milella, M | 1 |
| Vaccaro, A | 1 |
| D'Ottavio, AM | 1 |
| Papaldo, P | 1 |
| Nisticò, C | 1 |
| Thorel, MF | 1 |
| Marsella, A | 1 |
| Carpino, A | 1 |
| Giannarelli, D | 1 |
| Terzoli, E | 1 |
| Cognetti, F | 1 |
| Wessel, I | 1 |
| Mogielski, K | 1 |
| Heieck, B | 1 |
| Aebi, S | 1 |
| Gelber, S | 1 |
| Thürlimann, B | 1 |
| Werner, ID | 1 |
| Liao, Z | 1 |
| Strom, EA | 1 |
| Singletary, SE | 5 |
| Hunt, K | 1 |
| Allen, PK | 1 |
| McNeese, MD | 3 |
| Cao, TM | 1 |
| Negrin, RS | 1 |
| Stockerl-Goldstein, KE | 1 |
| Johnston, LJ | 1 |
| Shizuru, JA | 1 |
| Taylor, TL | 1 |
| Rizk, NW | 1 |
| Wong, RM | 1 |
| Blume, KG | 1 |
| Hu, WW | 1 |
| Yoshimura, M | 1 |
| Koizumi, K | 1 |
| Satani, K | 1 |
| Kakizaki, D | 1 |
| Kawanishi, Y | 1 |
| Ohyashiki, K | 1 |
| Abe, K | 1 |
| Higgins, JP | 1 |
| Warnke, RA | 1 |
| Lyons, JA | 1 |
| Myles, J | 1 |
| Pohlman, B | 1 |
| Macklis, RM | 1 |
| Crowe, J | 1 |
| Crownover, RL | 1 |
| Sauter, C | 1 |
| Fernandez, Y | 1 |
| Ramakrishnan, R | 1 |
| Rathinavelu, A | 1 |
| Takigawa, N | 1 |
| Segawa, Y | 1 |
| Saeki, T | 1 |
| Kataoka, M | 1 |
| Ida, M | 1 |
| Kishino, D | 1 |
| Fujiwara, K | 1 |
| Ohsumi, S | 1 |
| Eguchi, K | 1 |
| Takashima, S | 1 |
| Brito, RA | 1 |
| Valero, V | 1 |
| Booser, DJ | 1 |
| Ames, F | 1 |
| Strom, E | 1 |
| Ross, M | 1 |
| Theriault, RL | 2 |
| Frye, D | 2 |
| Kau, SW | 2 |
| Asmar, L | 1 |
| McNeese, M | 1 |
| Hortobagyi, GN | 5 |
| Bernardo, MV | 1 |
| Harrington, DP | 1 |
| Page, DL | 1 |
| Allred, DC | 1 |
| Dressler, LG | 1 |
| Hatfield, AK | 1 |
| Robert, NJ | 1 |
| Genvresse, I | 1 |
| Lange, C | 1 |
| Schanz, J | 1 |
| Schweigert, M | 1 |
| Harder, H | 1 |
| Possinger, K | 1 |
| Späth-Schwalbe, E | 1 |
| Windrum, P | 1 |
| Morris, TC | 1 |
| Catherwood, MA | 1 |
| Alexander, HD | 1 |
| McManus, DT | 1 |
| Markey, GM | 1 |
| Frayfer, J | 1 |
| Fadel, C | 1 |
| Cebotaru, C | 1 |
| Laribi, K | 1 |
| Fenaux, P | 1 |
| Amir, G | 1 |
| Rachmilewitz, EA | 1 |
| Al Omran, S | 1 |
| Mourad, WA | 1 |
| Ali, MA | 1 |
| O'Connell, MJ | 2 |
| Májský, A | 1 |
| Abrahámová, J | 2 |
| Wilson, R | 1 |
| Hanham, IW | 1 |
| Mair, G | 1 |
| Drake, SR | 1 |
| Derry, CD | 1 |
| McKenzie, C | 1 |
| Stoll, BA | 2 |
| Boesen, E | 1 |
| Skeggs, DB | 1 |
| Senanayake, F | 1 |
| Wagner, HP | 1 |
| Blechschmidt, CM | 1 |
| Schermuly, W | 1 |
| Bruntsch, U | 2 |
| Livingston, RB | 3 |
| Nüvemann, M | 1 |
| Fernholz, HJ | 1 |
| Frik, W | 1 |
| Blum, E | 1 |
| Bauer, M | 1 |
| Band, P | 1 |
| Morris, D | 1 |
| Elias, EG | 1 |
| Wiernik, PH | 1 |
| Sarg, MJ | 1 |
| Corder, MP | 1 |
| Sheets, RF | 1 |
| Stone, WH | 1 |
| Flannery, EP | 1 |
| Justice, GR | 1 |
| Herbst, KD | 1 |
| Gross, NJ | 1 |
| Obrecht, P | 3 |
| Maurice, P | 1 |
| Mouridsen, HT | 5 |
| Palshof, T | 3 |
| Muss, HB | 2 |
| White, DR | 2 |
| Richards, F | 2 |
| Spurr, CL | 2 |
| Frederiksen, PL | 2 |
| Joergensen, ST | 1 |
| Roesdahl, K | 1 |
| Thomsen, J | 1 |
| Stuart, JJ | 1 |
| Jackson, DV | 1 |
| Rhyne, L | 1 |
| Amgwerd, R | 1 |
| Sprenger, F | 1 |
| Hochuli, E | 1 |
| Engelhart, G | 1 |
| Heinz, C | 1 |
| Wick, A | 1 |
| Enderlin, F | 1 |
| Simeon, B | 1 |
| Lanz, R | 1 |
| Bigler, R | 1 |
| Brown, TC | 1 |
| Mayr, AC | 3 |
| Britell, JC | 1 |
| Lippman, ME | 2 |
| Dietz, R | 1 |
| Tkocz, HJ | 1 |
| García Puche, JL | 1 |
| Ballesteros, P | 1 |
| Cueto, J | 1 |
| Rodríguez, PA | 1 |
| Talavera, MC | 1 |
| Tsiliacos, SC | 1 |
| Athanasiou, AE | 1 |
| McPherson, A | 1 |
| Paterson, S | 1 |
| Lees, A | 1 |
| Sohier, WD | 1 |
| Kaufman, S | 2 |
| Weitzman, SA | 1 |
| Kelley, RM | 1 |
| Lew, RA | 1 |
| Halpern, E | 1 |
| Estapé, J | 1 |
| Millá, A | 1 |
| Prats, M | 1 |
| Herranz, M | 1 |
| Visa, J | 1 |
| Sponzo, RW | 1 |
| Cunningham, TJ | 1 |
| Caradonna, RR | 1 |
| Antemann, R | 1 |
| Diaz, R | 1 |
| Dao, T | 1 |
| Steinbaum, FL | 1 |
| De Jager, RL | 1 |
| Krakoff, IH | 1 |
| Mascia, V | 1 |
| Massidda, B | 1 |
| Pellegrini, A | 1 |
| Bugarski, M | 1 |
| Vuletić, L | 1 |
| Boberić, J | 1 |
| Milosavljević, A | 1 |
| Dilparić, S | 1 |
| Tomin, R | 2 |
| Naumović, P | 1 |
| Biran, S | 3 |
| Haskell, CM | 1 |
| Sparks, FC | 1 |
| Graze, PR | 1 |
| Korenman, SG | 1 |
| Vanderploeg, DE | 1 |
| Viola, MV | 1 |
| Nystrom, JS | 1 |
| Legha, SS | 1 |
| Flubacher, P | 1 |
| Meier, V | 1 |
| Hartmann, D | 1 |
| Hansen, M | 1 |
| Osterlind, K | 1 |
| Hansen, HH | 1 |
| Mouridsen, H | 1 |
| Brahm, M | 1 |
| Rahbek, I | 1 |
| West, JH | 1 |
| George, SL | 1 |
| Samal, B | 2 |
| Bonnet, JD | 1 |
| Braine, H | 1 |
| Siering, H | 1 |
| Felsch, G | 1 |
| Barthel, E | 1 |
| Murphy, S | 1 |
| Huguley, CM | 1 |
| Barndt, J | 1 |
| Lozada, JA | 1 |
| Grillo-López, A | 1 |
| Blomgren, H | 1 |
| Baral, E | 1 |
| Petrini, B | 1 |
| Wasserman, J | 1 |
| Mitchell, MS | 1 |
| Gallmeier, WM | 1 |
| Schmidt, CG | 2 |
| Gold, GL | 3 |
| Chabner, BA | 4 |
| Schein, PS | 3 |
| Young, RC | 3 |
| Farmer, W | 1 |
| Ravin, C | 1 |
| Schachter, EN | 1 |
| Eagan, RT | 1 |
| Steinfeld, JL | 1 |
| Taylor, WF | 1 |
| Ehrhart, H | 1 |
| Klotz, J | 1 |
| Strawitz, JG | 1 |
| Wilson, WL | 1 |
| Cornell, GN | 1 |
| Madden, RE | 1 |
| Gasecki, AP | 1 |
| Bashir, RM | 1 |
| Foley, J | 1 |
| McCarthy, GM | 1 |
| Skillings, JR | 1 |
| Albain, KS | 1 |
| LeBlanc, M | 1 |
| Rivkin, S | 2 |
| Smith, TL | 4 |
| Fraschini, G | 3 |
| Holmes, FA | 3 |
| Gutterman, JU | 1 |
| Hug, VM | 1 |
| Ames, FC | 3 |
| Glick, J | 2 |
| Falkson, CI | 1 |
| Pisansky, TM | 1 |
| Schaid, DJ | 5 |
| Donohue, JH | 1 |
| Schray, MF | 1 |
| Schomberg, PJ | 1 |
| Rischin, D | 1 |
| Laidlaw, CR | 1 |
| Zimet, A | 1 |
| Jeal, P | 1 |
| Dipell, JF | 1 |
| Rodger, A | 1 |
| Jack, WJ | 1 |
| Hardman, PD | 1 |
| Kerr, GR | 1 |
| Mohapatro, SK | 1 |
| Dandapat, MC | 1 |
| Padhi, NC | 1 |
| Lombardi, C | 1 |
| Calvi, A | 1 |
| Bonera, E | 1 |
| Savio, A | 1 |
| Savio, E | 1 |
| Eudey, L | 1 |
| Gilchrist, KW | 3 |
| Levine, MN | 5 |
| Bramwell, V | 2 |
| Abu-Zahra, H | 2 |
| Goodyear, MD | 2 |
| Arnold, A | 3 |
| Findlay, B | 2 |
| Skillings, J | 2 |
| Gent, M | 3 |
| Luboinski, G | 1 |
| Nagadowska, M | 1 |
| Pienkowski, T | 1 |
| Schulman, P | 2 |
| Kerr, LD | 1 |
| Spiera, H | 1 |
| Hartmann, LC | 1 |
| Lichtman, SM | 1 |
| Bosworth, H | 1 |
| Allen, S | 1 |
| Weiselberg, L | 1 |
| Weiss, R | 2 |
| Lehrman, D | 1 |
| Vinciguerra, V | 1 |
| Ro, J | 1 |
| Sahin, A | 1 |
| Ro, JY | 1 |
| Fritsche, H | 1 |
| Blick, M | 1 |
| Schleifer, SJ | 1 |
| Lebovits, A | 1 |
| Tanaka, JS | 1 |
| Messe, M | 1 |
| Strain, JJ | 1 |
| Levine, EG | 1 |
| Raczynski, JM | 1 |
| Carpenter, JT | 1 |
| Schutt, AJ | 1 |
| Buckner, JC | 2 |
| Long, HJ | 1 |
| Petru, E | 2 |
| Schmähl, D | 2 |
| Abner, AL | 1 |
| Recht, A | 1 |
| Vicini, FA | 1 |
| Silver, B | 1 |
| Hayes, D | 1 |
| Come, S | 1 |
| Harris, JR | 1 |
| Samal, BA | 1 |
| Redman, B | 1 |
| Flaherty, L | 1 |
| Kraut, M | 1 |
| Simon, M | 1 |
| Valdivieso, M | 1 |
| Dorr, A | 1 |
| Jacquillat, C | 3 |
| Weil, M | 2 |
| Baillet, F | 3 |
| Borel, C | 1 |
| Auclerc, G | 2 |
| de Maublanc, MA | 1 |
| Housset, M | 3 |
| Forget, G | 1 |
| Thill, L | 2 |
| Soubrane, C | 2 |
| Wolberg, WH | 1 |
| Gillchrist, KW | 1 |
| Harris, JE | 1 |
| Watsky, KL | 1 |
| Orlow, SJ | 1 |
| Bolognia, JL | 1 |
| Hryniuk, WM | 2 |
| DePauw, S | 1 |
| Levin, L | 2 |
| Camoriano, JK | 1 |
| Therneau, TM | 1 |
| Krook, JE | 6 |
| Veeder, MH | 1 |
| Koh, EH | 1 |
| Hug, V | 2 |
| Tomek, R | 1 |
| Price, LA | 1 |
| Hill, BT | 1 |
| Cebon, JS | 1 |
| Harvey, V | 2 |
| Mason, B | 1 |
| Jeal, PN | 2 |
| Içli, F | 1 |
| Dinçol, D | 1 |
| Unal, M | 1 |
| Grage, T | 1 |
| Wolter, J | 1 |
| Woll, JE | 1 |
| Palta, M | 1 |
| Love, RR | 2 |
| Nunnink, JC | 1 |
| Krusinski, PA | 1 |
| Yates, JW | 1 |
| Lowenthal, RM | 1 |
| Jestrimski, KW | 1 |
| Borden, EC | 1 |
| Hawkins, MJ | 1 |
| Yahalom, J | 1 |
| Sulkes, A | 3 |
| Thoms, WW | 1 |
| Fletcher, GH | 1 |
| Oswald, MJ | 1 |
| Wall, JG | 1 |
| Dessard-Diana, B | 1 |
| Michel-Langlet, P | 1 |
| Alapetite, C | 1 |
| Voigtmann, R | 1 |
| Kobayashi, R | 1 |
| Osada, T | 1 |
| Hamaguchi, M | 1 |
| Ohi, T | 1 |
| Inden, Y | 1 |
| Hara, K | 1 |
| Tomiyama, J | 1 |
| Kitayama, J | 1 |
| Tsukui, G | 1 |
| Kobori, O | 1 |
| Everson, LK | 4 |
| Wieand, HS | 2 |
| Cullinan, SA | 5 |
| Wold, LE | 2 |
| Hagen, JB | 1 |
| Martin, JK | 2 |
| Fitzgibbons, RG | 1 |
| Mailliard, JA | 1 |
| Pfeifle, DM | 3 |
| Votava, HJ | 2 |
| Ebbert, LP | 1 |
| Windschitl, HE | 2 |
| Knuiman, MW | 1 |
| Sleeper, LA | 1 |
| Constanzi, JJ | 1 |
| Stewart, HJ | 1 |
| Schoen, HD | 1 |
| Wendt, T | 1 |
| Potrebica, V | 2 |
| Marshall, JS | 1 |
| Arafah, BM | 1 |
| McGuire, W | 1 |
| Ang, PT | 1 |
| Kau, S | 2 |
| Huan, S | 1 |
| Pazdur, R | 1 |
| Singhakowinta, A | 1 |
| Vaitkevicius, VK | 1 |
| Foitl, DR | 1 |
| Hyman, G | 1 |
| Lefkowitch, JH | 1 |
| Leventhal, H | 1 |
| Easterling, DV | 1 |
| Nerenz, DR | 1 |
| Feffer, SE | 1 |
| Carmosino, LS | 1 |
| Fox, RL | 1 |
| Jakobsen, A | 1 |
| Møller, KA | 1 |
| Andersen, AP | 1 |
| Brincker, H | 1 |
| Dombernowsky, P | 1 |
| Hansen, PV | 1 |
| Hesselius, I | 1 |
| Kjaer, M | 1 |
| Gupta, AK | 1 |
| Davies, GM | 1 |
| Haberman, HF | 1 |
| Paulsen, JK | 1 |
| Twito, DI | 1 |
| Ward, JH | 1 |
| Eyre, HJ | 1 |
| Liu, GS | 1 |
| Li, GC | 1 |
| Auclerc, M | 1 |
| Sellami, M | 1 |
| Jindani, A | 1 |
| Fowble, B | 1 |
| Goodman, R | 1 |
| Mechl, Z | 1 |
| Sopkova, B | 1 |
| Marcus, C | 1 |
| Martin, RG | 1 |
| Matsuoka, T | 1 |
| Yoshimoto, S | 1 |
| Sonobe, H | 1 |
| Kiyoku, Y | 1 |
| Yamasaki, M | 1 |
| Taguchi, H | 1 |
| Miyoshi, I | 1 |
| Buzdar, A | 1 |
| Montague, E | 1 |
| Powles, T | 1 |
| Powis, G | 1 |
| Reece, P | 1 |
| Macchiavelli, M | 1 |
| Strauss, E | 1 |
| Goldar, D | 1 |
| Alvarez, LA | 1 |
| Vallejo, C | 1 |
| Janjan, NA | 1 |
| Wilson, JF | 1 |
| Gillin, M | 1 |
| Anderson, T | 1 |
| Greenberg, M | 1 |
| Schewe, K | 1 |
| Cox, JD | 1 |
| Hirsh, J | 1 |
| De Pauw, S | 1 |
| Fowble, BL | 1 |
| Rosato, EF | 1 |
| Mackie, JA | 1 |
| Weiler, C | 1 |
| Glover, DJ | 1 |
| Fox, KR | 1 |
| Hurwitz, S | 1 |
| Goodwin, PJ | 1 |
| Cantinho-Lopes, MG | 1 |
| Godinho, F | 1 |
| Sales-Luis, A | 1 |
| España, P | 1 |
| Bonilla, F | 1 |
| Yebra, M | 1 |
| Diego, J | 1 |
| Alvarez de Mon, M | 1 |
| Marazuela, M | 1 |
| Durántez, A | 1 |
| Merino Moreno, J | 1 |
| Núñez Olarte, JM | 1 |
| Picó Sambucety, JM | 1 |
| Pastor Gómez-Cornejo, L | 1 |
| Ortega Núñez, A | 1 |
| Rasmussen, P | 1 |
| Chang, AY | 1 |
| Goodyear, M | 1 |
| Carvalho, V | 1 |
| Tancini, G | 2 |
| Zambetti, M | 2 |
| Bignami, P | 1 |
| Di Fronzo, G | 1 |
| Silvestrini, R | 1 |
| McDivitt, RW | 1 |
| O'Bryan, R | 1 |
| Knuiman, M | 1 |
| Marcus, CE | 1 |
| Martin, R | 1 |
| Gehan, EA | 1 |
| Ellis, ME | 1 |
| Lesnick, GJ | 2 |
| Schulman, S | 1 |
| Griffin, BR | 1 |
| Goldberg, RS | 1 |
| Fabian, CJ | 3 |
| Hammond, N | 1 |
| Hynes, H | 1 |
| Swain, SM | 1 |
| Blaustein, JC | 1 |
| Lewkow, L | 1 |
| Weinberg, V | 1 |
| Korzun, A | 1 |
| Ginsberg, S | 1 |
| Gebski, V | 1 |
| Woods, RL | 1 |
| Snyder, R | 1 |
| Byrne, M | 1 |
| Gill, G | 1 |
| Vogel, CL | 1 |
| Raney, M | 1 |
| Shah, LL | 1 |
| Pretorius, FJ | 1 |
| Knobf, MT | 1 |
| Lane, WW | 2 |
| Boyages, J | 1 |
| Mead, GM | 1 |
| Sweetenham, JW | 1 |
| Ewins, DL | 1 |
| Furlong, M | 1 |
| Lowes, JA | 1 |
| Zelen, M | 1 |
| Gelber, R | 1 |
| Gez, E | 2 |
| Pfeffer, MR | 1 |
| Catane, R | 2 |
| Isacson, R | 2 |
| Dnistrian, AM | 1 |
| Greenberg, EJ | 1 |
| Dillon, HJ | 1 |
| Hakes, TB | 1 |
| Fracchia, AA | 1 |
| Schwartz, MK | 1 |
| Huntington, MO | 1 |
| Rosenberg, A | 1 |
| Cadman, E | 1 |
| Veronesi, U | 1 |
| Nekliudova, VI | 1 |
| Seregin, GI | 1 |
| Shkhvatsabaia, LV | 1 |
| Rafla, S | 1 |
| Tranum, W | 1 |
| Constanzi, J | 1 |
| McDivitt, R | 2 |
| Cruz, T | 2 |
| Wilmanns, W | 1 |
| Binsack, T | 1 |
| Sauer, H | 1 |
| Sertoli, MR | 1 |
| Scarsi, PG | 1 |
| Rosso, R | 1 |
| Carter, SK | 3 |
| Kalish, LA | 1 |
| Cummings, F | 1 |
| Bennett, JM | 1 |
| Wolmark, N | 1 |
| Fisher, B | 1 |
| Bowman, WD | 1 |
| Laurie, JA | 1 |
| Segaloff, A | 1 |
| Hankey, BF | 1 |
| Carter, AC | 1 |
| Escher, GC | 2 |
| Ansfield, FJ | 5 |
| Talley, RW | 1 |
| Mortimer, J | 1 |
| Flournoy, N | 1 |
| Gargan, TJ | 1 |
| Come, SE | 1 |
| Satwicz, PR | 1 |
| Rubens, RD | 1 |
| Savage, D | 1 |
| Garrett, TJ | 1 |
| Taguchi, T | 1 |
| Heasman, KZ | 1 |
| Sutherland, HJ | 1 |
| Campbell, JA | 1 |
| Elhakim, T | 1 |
| Weshler, Z | 1 |
| Shingleton, WW | 2 |
| Sedransk, N | 2 |
| Johnson, RO | 2 |
| Sievers, DB | 1 |
| Donovan, AJ | 2 |
| Malaviya, AN | 1 |
| Many, A | 1 |
| Schwartz, RS | 1 |
| Gleason, TH | 1 |
| Hamlin, WB | 1 |
| Davis, HL | 4 |
| Wiseley, AN | 1 |
| Gorins, A | 1 |
| Bloch-Michel, H | 1 |
| Dussart, N | 1 |
| Aristoff, H | 1 |
| Perrault, JL | 1 |
| Janis, M | 1 |
| Wolinsky, H | 1 |
| Krain, LS | 1 |
| Bierman, SM | 1 |
| Rosenoff, SH | 1 |
| Wolf, ML | 1 |
| Olsnes, S | 1 |
| Pihl, A | 1 |
| Byland, W | 1 |
| Nagel, G | 1 |
| Smith, P | 1 |
| Nagel, GA | 2 |
| Larson, SM | 1 |
| Graff, KS | 1 |
| Tretner, IH | 1 |
| Zager, RF | 1 |
| Henderson, EA | 1 |
| Johnston, GS | 1 |
| Prout, MN | 1 |
| McKenna, PJ | 1 |
| Cole, DR | 1 |
| Korbitz, BC | 2 |
| Stutz, FH | 2 |
| Blom, J | 2 |
| Melchert, F | 1 |
| Brennan, MJ | 1 |
| Skarin, AT | 2 |
| Oproiu, A | 1 |
| Goldenberg, IS | 1 |
| McMahan, CA | 1 |
| Volk, H | 1 |
| Olson, KB | 1 |
| Kingry, RL | 1 |
| Hobson, RW | 1 |
| Muir, RW | 1 |
| Barb, U | 1 |
| Vielberg, H | 1 |
| Hoppe, D | 1 |
| Bronsch, T | 1 |
| Gudowski, J | 1 |
| Goldstein, M | 1 |
| Sugarbaker, PH | 1 |
| Wilson, RE | 3 |
| Frei, E | 1 |
| Spigel, SC | 1 |
| Coltman, CA | 1 |
| van Kaick, G | 1 |
| Drings, P | 1 |
| Fritsch, H | 1 |
| Moskwa, G | 1 |
| Lee, JM | 1 |
| Lenhard, RE | 1 |
| Steward, AM | 1 |
| Nixon, D | 1 |
| Zamcheck, N | 1 |
| Aisenberg, A | 1 |
| Billund, JK | 1 |
| Ellerby, RA | 1 |
| Scott, WP | 1 |
| Piro, AJ | 2 |
| Aliapoulios, MA | 2 |
| Nevinny, HB | 1 |
| Lee, CA | 1 |
| Lloyd, HM | 1 |
| Kaae, S | 1 |
| Skjoldborg, H | 1 |
| Bollag, W | 1 |
| Jakoubková, J | 1 |
| Havránková, N | 1 |
| Heinemann, HO | 1 |
| Fierer, JA | 1 |
| Wagner, BM | 1 |
| Strebel, RF | 1 |
| Vansant, JH | 1 |
| Payne, RL | 1 |
| Wheeler, JR | 1 |
| Laugier, P | 1 |
| Risold, JC | 1 |
| Ellena, V | 1 |
| Péquégnot, F | 1 |
| Barale, T | 1 |
| Ahlquist, KA | 1 |
| Jackson, AW | 1 |
| Stewart, JG | 2 |
| Hartog, M | 1 |
| Joplin, GF | 1 |
| Herter, FP | 1 |
| Mulcare, RJ | 1 |
| McCarthy, JG | 1 |
| Gump, FE | 1 |
| Ukai, M | 1 |
| Buckley, K | 1 |
| Wheeler, B | 1 |
| Szreder, W | 1 |
| Firat, D | 1 |
| Olshin, S | 1 |
| Skinner, LG | 1 |
| O'Connor, PJ | 1 |
| Góis, JS | 1 |
| Ayrosa, RC | 1 |
| da Silva, AS | 1 |
| Ugaz, LM | 1 |
| Bethune, JE | 1 |
| Berne, TV | 1 |
| Doorenbos, H | 1 |
| Kostanecki, W | 1 |
| Kwiatkowska, E | 1 |
| Zborzil, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 2 Clinical Trial:Low -Dose-bevacizumab and Pemetrexed Versus Treatment of Physician's Choice in Metastatic HER2-negative Breast Cancer Patients After Failure of Taxanes and Anthracycline-containing Regimens[NCT02829008] | Phase 2 | 120 participants (Anticipated) | Interventional | 2016-04-30 | Active, not recruiting | ||
| Matched Pair Analysis Comparing the Outcomes of Primary Breast and Nodal Diffuse Large B Cell Lymphoma in Patients Treated With R-CHOP; Consortium for Improving Survival of Lymphoma (CISL) Study[NCT01266668] | 100 participants (Actual) | Observational | 2010-02-28 | Completed | |||
| Multi-center Phase II Study of the Combination of R-CHOP (RItuximab Plus Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) and Prophylactic Intrathecal Chemotherapy With Methotrexate in Patients With CD20+ Primary Breast Diffuse Large B-cell Ly[NCT01448096] | Phase 2 | 33 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| The Effects of Exercise Training on Tumor Vascularity and Response to Neoadjuvant Therapy in Operable Breast Cancer: A Phase I-II Study[NCT00405678] | Phase 1/Phase 2 | 23 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| A Randomized Study of a New Medical Device for Oral Mucositis (MDOM Trial)[NCT05104268] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2021-11-30 | Not yet recruiting | ||
| A Phase 1/Phase 2 Study for the Prevention of Oral Mucositis (SPOM)[NCT05338398] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2022-04-15 | Enrolling by invitation | ||
| Phase I Study of Multiple Ascending Dose, to Investigate the Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy[NCT05308732] | Phase 1 | 36 participants (Anticipated) | Interventional | 2021-05-11 | Recruiting | ||
| Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the BK0023 Injectable Formulation vs. Neupogen®[NCT01933971] | Phase 1 | 102 participants (Actual) | Interventional | 2007-06-30 | Completed | ||
| A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients[NCT00001384] | Phase 2 | 35 participants | Interventional | 1994-05-31 | Completed | ||
| A Pilot Trial of Sequential Primary (Neoadjuvant) Combination Chemotherapy With Docetaxel/Capecitabine (TX) and Doxorubicin/Cyclophosphamide (AC) in Primary Breast Cancer With Evaluation of Chemotherapy Effects on Gene Expression[NCT00005908] | Phase 2 | 30 participants (Actual) | Interventional | 2000-06-30 | Completed | ||
| A Phase 1b Followed by Phase II Expansion Trial of Combination of Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer (ComPACT)[NCT05491083] | Phase 1/Phase 2 | 51 participants (Anticipated) | Interventional | 2023-06-12 | Recruiting | ||
| Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Old Patients With Breast Cancer[NCT04033965] | 345 participants (Actual) | Observational | 1997-09-03 | Completed | |||
| Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment: a Prospective Cohort Study on Patients Affected by Breast Cancer[NCT03210441] | 204 participants (Anticipated) | Observational | 2014-05-06 | Recruiting | |||
| Adjuvant Dose-dense Sequential Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study[NCT04829890] | 89 participants (Actual) | Observational | 2004-02-29 | Completed | |||
| Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial[NCT00001250] | Phase 2 | 130 participants | Interventional | 1989-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Here is the number of participants with adverse events. For the detailed list of adverse events see the adverse event module. (NCT00005908)
Timeframe: 6 years
| Intervention | Participants (Number) |
|---|---|
| Dose A-Cohort 1-Arm 1-Docetaxel & Capecitabine | 9 |
| Dose B-Cohort 2-Arm 2 Reduced Dose-Docetaxel & Capecitabine | 20 |
Patients were classified as responders or non-responders based on change in tumor size by clinical exam and pathologic response.For instance, patients with a pathological complete response, micro-invasive disease at surgery, or clinical complete response after four cycles of treatment were considered responders. Changes in gene expression associated with treatment was assessed before/after chemotherapy. All gene expression summary intensities below 50 were thresholded to the value of 50 and genes showing variability significantly smaller than the median gene variability were screened out. (NCT00005908)
Timeframe: 6 years
| Intervention | Participants (Number) | |
|---|---|---|
| Responders | Non-responders | |
| Dose A-Cohort 1-Arm 1-Docetaxel & Capecitabine | 8 | 2 |
| Dose B-Cohort 2-Arm 2 Reduced Dose-Docetaxel & Capecitabine | 7 | 13 |
Patients were classified as responders or non-responders based on change in tumor size by clinical exam and pathologic response.For instance, patients with a pathological complete response, micro-invasive disease at surgery, or clinical complete response after four cycles of treatment were considered responders. Changes in gene expression associated with treatment was assessed before/after chemotherapy. All gene expression summary intensities below 50 were thresholded to the value of 50 and genes showing variability significantly smaller than the median gene variability were screened out. (NCT00005908)
Timeframe: 6 years
| Intervention | Participants (Number) | |
|---|---|---|
| Responders | Non-responders | |
| Dose A & B-Cohort 1 & 2-Arm 1 & 2-Docetaxel & Capecitabine | 8 | 13 |
Overall response rate is defined as the percentage of participants with a CR (complete disappearance of all target lesions), PR (a 30% decrease in the sum of the longest diameter of target lesions) determined by clinical measurements per the Response Evaluation Criteria in Solid Tumors (RECIST) and/or a complete pathologic response (disappearance of all invasive tumor pathologically or presence of ductal carcinoma in situ) per the Chevallier criteria. For details about the RECIST or Chevallier criteria see the protocol link module. (NCT00005908)
Timeframe: 6 years
| Intervention | Percentage of participants (Number) | ||
|---|---|---|---|
| Complete Response | Partial Response | Complete pathologic response | |
| Dose A & B-Cohort 1 & 2-Arm 1& 2-Docetaxel & Capecitabine | 31 | 59 | 10 |
56 reviews available for prednisone and Breast Cancer
| Article | Year |
|---|---|
Primary diffuse large B cell lymphoma of the lactating left breast. A case report and review of the literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cycl | 2020 |
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2013 |
Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.
Topics: Administration, Oral; Adult; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Dip | 2015 |
[Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 2015 |
Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breas | 2017 |
Extranodal lymphoma: a reappraisal.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2008 |
Breast cancer after treatment of Hodgkin's lymphoma: general review.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2008 |
[Problems and future direction of preoperative systemic therapy for patients with operable breast cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast | 2008 |
Palmar fasciitis with polyarthritis syndrome in a patient with breast cancer.
Topics: Adult; Anti-Inflammatory Agents; Arthritis; Breast Neoplasms; Carcinoma, Ductal; Combined Modality T | 2011 |
Critical appraisal of cabazitaxel in the management of advanced prostate cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cl | 2010 |
Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.
Topics: Alendronate; Antineoplastic Protocols; Arthritis; Breast Neoplasms; Combined Modality Therapy; Derma | 2011 |
Radiation-induced bronchiolitis obliterans organizing pneumonia.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intra | 2012 |
Association of breast cancer and immune thrombocytopenic purpura.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Glucocorticoids; Hu | 2002 |
Primary breast lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2003 |
[ENDOCRINE TREATMENT OF METASTASISED MAMMARY CARCINOMA].
Topics: Anabolic Agents; Androgens; Breast; Breast Neoplasms; Castration; Estrogens; Female; Humans; Hypophy | 1963 |
ENDOCRINE TREATMENT OF METASTASISED MAMMARY CARCINOMA.
Topics: Anabolic Agents; Androgens; Breast; Breast Neoplasms; Castration; Estrogens; Female; Humans; Hypophy | 1963 |
[New antibodies in cancer treatment].
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti | 2004 |
Primary non-Hodgkin's lymphoma of the breast: report of a case with special reference to 380 cases in the Japanese literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cy | 2005 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 2006 |
[Primary breast lymphoma--a report of 27 cases with literature review].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast N | 2007 |
[Recent developments in chemotherapy of malignant diseases].
Topics: Anthraquinones; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 1982 |
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Re | 1984 |
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Re | 1984 |
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Re | 1984 |
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Re | 1984 |
Hormone receptors. An update and application.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Combined Modality The | 1984 |
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrog | 1981 |
Estrogens and breast cancer.
Topics: Adrenal Glands; Androgens; Biological Transport; Breast; Breast Neoplasms; Estrogen Antagonists; Est | 1981 |
Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Topics: Adult; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; | 1981 |
The use of mitoxantrone in the treatment of breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials a | 1995 |
The radiographic diagnosis and treatment of paraneoplastic central nervous system disease.
Topics: Aged; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Dex | 1994 |
Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 1993 |
[Primary MALT-type lymphoma of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1998 |
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1998 |
Breast metastasis from multiple myeloma: report of a case and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Fatal Outcome; Female; Humans; Mel | 1998 |
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, | 2000 |
Chemotherapy of solid tumors. Recent advances.
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinom | 1976 |
[The state of hormone and chemotherapy in breast neoplasms].
Topics: Androgens; Brain Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therap | 1978 |
Chemotherapy for breast cancer.
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Dr | 1979 |
Pulmonary effects of radiation therapy.
Topics: Animals; Breast Neoplasms; Diagnosis, Differential; Humans; Lung; Lung Diseases; Lung Neoplasms; Ple | 1977 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
The role of chemotherapy in the treatment of cancer of the breast.
Topics: Breast Neoplasms; Castration; Cyclophosphamide; Drug Resistance; Estrogens; Female; Fluorouracil; Hu | 1975 |
Leptomeningeal carcinomatosis: a report of 3 cases and review of the literature.
Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Smal | 1992 |
Autotransplantation in solid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1991 |
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod | 1991 |
Adjuvant therapy in breast cancer.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin | 1990 |
Figurate and bullous eruption in association with breast carcinoma.
Topics: Aged; Breast Neoplasms; Combined Modality Therapy; Erythema; Female; Humans; Methotrexate; Prednison | 1990 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast | 1986 |
Biologic response modifiers as adjuncts to other therapeutic modalities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast | 1986 |
Treatment of advanced breast cancer with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 1988 |
Controversies in the treatment of cancer of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1987 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 1985 |
Adjuvant therapy in primary breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Hormono-chemotherapy in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
Topics: Adult; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Com | 1985 |
Systemic adjuvant therapy and breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cost-Ben | 1985 |
The chemical therapy of breast cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; | 1974 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
Corticosteroids in the treatment of solid tumors.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Brain Edema; Brain Neoplasms; Breast Neoplasms; Chil | 1973 |
181 trials available for prednisone and Breast Cancer
| Article | Year |
|---|---|
Primary breast lymphoma: A single-centre experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2019 |
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growt
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protoc | 2010 |
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2012 |
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2012 |
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2012 |
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antin | 2012 |
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Axil | 2003 |
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cause of Deat | 2003 |
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Proto | 2003 |
Primary breast lymphoma: results of a controlled clinical trial.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2005 |
[Clinical observation on treatment of radiation pneumonia by Qingjin Runfei Decoction combined with hormone and antibiotic].
Topics: Adult; Aged; Anti-Bacterial Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Therapy, | 2007 |
Rituximab and dose dense chemotherapy in primary breast lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2007 |
Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neop | 1983 |
[Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer].
Topics: Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Ovary; Predni | 1983 |
A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; BCG Vaccine; Breast Neoplasms; | 1983 |
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Adjuvant therapy of breast cancer: the Southwest Oncology Group experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1983 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; | 1983 |
High-dose versus low-dose CMFP regimen in advanced breast cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Tri | 1984 |
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials | 1984 |
CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical T | 1984 |
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood; Breast Neoplasms; Cisplatin; Clinical Trials | 1984 |
Breast cancer 1984: state of the art.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Tr | 1984 |
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1984 |
Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trial | 1984 |
Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1984 |
Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1984 |
Review: experience of randomized trials without surgical controls.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1984 |
Southeastern Cancer Study Group: breast cancer studies 1972-1982.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabin | 1983 |
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Chlorambucil; Combined | 1983 |
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neopla | 1983 |
Body weight and prognosis in breast cancer.
Topics: Adult; Aged; Body Height; Body Weight; Breast Neoplasms; Castration; Female; Hormones; Humans; Menst | 1981 |
Treatment of breast cancer with oral four-drug chemotherapy.
Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosph | 1980 |
Multimodal treatment of primary breast carcinoma: analysis of accomplishments and problem areas.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Estrog | 1981 |
Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Ther | 1980 |
Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Topics: Adult; Animals; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; | 1981 |
Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 1981 |
Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Doxorubicin; Drug A | 1980 |
Surgical adjuvant trials in the United States.
Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Dr | 1980 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Ova | 1980 |
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug The | 1982 |
Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Dr | 1982 |
Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Dr | 1982 |
[Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 1982 |
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Flu | 1982 |
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as T | 1982 |
Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubic | 1982 |
An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advances breast cancer undergoing oophorectomy: a later analysis.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Castration; Clinical Trials as Topic; Cyclophosphami | 1982 |
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clin | 1982 |
Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Th | 1982 |
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 1995 |
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distributi | 1995 |
Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cy | 1995 |
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemother | 1994 |
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adju | 1994 |
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ch | 1994 |
Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Chemotherap | 1994 |
Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Combined Mo | 1994 |
Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorouracil; | 1993 |
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1993 |
An intensive sequenced adjuvant chemotherapy regimen for breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Com | 1993 |
Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 1993 |
Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 1993 |
Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Combined | 1996 |
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1996 |
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 1996 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Combined Modality Therapy | 1996 |
[Sequencing of chemotherapy and radiotherapy following breast-preserving treatment of breast carcinoma].
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alky | 1996 |
A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1997 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axi | 1997 |
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neopla | 1998 |
Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 1997 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosph | 1998 |
Analysis of cause-specific failure endpoints using simple proportions: an example from a randomized controlled clinical trial in early breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Data Inte | 1998 |
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; | 1998 |
Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyc | 1998 |
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1999 |
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.
Topics: Adenocarcinoma; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Tra | 2000 |
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cohort Studies; De | 2000 |
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2001 |
Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 2001 |
Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer.
Topics: Adult; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; D | 1978 |
Adjuvant hormono-chemotherapy in operable breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Flu | 1978 |
Treatment of early breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug The | 1978 |
Chemotherapy of disseminated breast cancer. Current status and prospects.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Dr | 1977 |
Combined chemo- and hormonal therapy in advanced breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Castration; Chlorambucil; Clinical Trials as Topic; Cycloph | 1977 |
A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
Topics: Agranulocytosis; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; | 1977 |
Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphami | 1977 |
Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Drug Therapy, Com | 1977 |
Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Resista | 1978 |
Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
Topics: Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Do | 1978 |
Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Follow-Up Studies; Hum | 1979 |
Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug T | 1979 |
Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Topics: Antineoplastic Agents; BCG Vaccine; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cycloph | 1979 |
Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
Topics: Adrenalectomy; Aged; Bone Marrow; Breast Neoplasms; Cyclophosphamide; Digestive System; Doxorubicin; | 1978 |
An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy.
Topics: Adult; Age Factors; Breast Neoplasms; Castration; Cyclophosphamide; Drug Therapy, Combination; Evalu | 1977 |
[Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Comb | 1977 |
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; D | 1976 |
Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Adminis | 1976 |
[Chemotherapy of metastasizing breast cancers. Indications and results].
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fema | 1975 |
Combination chemotherapy in breast cancer: a randomized study of 4 versus 5 drugs.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle | 1975 |
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1992 |
A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1992 |
Locally advanced breast cancer: report of phase II study and subsequent phase III trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1992 |
Chemotherapy versus observation in high-risk node-negative breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Com | 1992 |
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp | 1992 |
Systemic adjuvant therapy in women with resected node-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1991 |
Autotransplantation in solid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1991 |
Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Evaluation | 1990 |
A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1991 |
Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Mo | 1990 |
Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 1990 |
Adjuvant therapy in breast cancer.
Topics: Adjuvants, Pharmaceutic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin | 1990 |
Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cl | 1990 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administrat | 1990 |
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Dru | 1990 |
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality The | 1990 |
cis-platinum-based alternating non-cross-resistant chemotherapy as a first-line treatment in metastatic breast cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1990 |
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1990 |
Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cause of Death; Combined Modality Therapy; Female; Follow | 1990 |
Biologic response modifiers as adjuncts to other therapeutic modalities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast | 1986 |
How to improve adjuvant treatment results in postmenopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; | 1989 |
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; C | 1989 |
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cl | 1989 |
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1989 |
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclopho | 1989 |
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1989 |
Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1989 |
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined | 1989 |
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1989 |
Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1989 |
Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; C | 1989 |
Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Clinical Trials | 1985 |
A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials | 1985 |
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1989 |
Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Injec | 1986 |
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Co | 1988 |
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1988 |
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1988 |
Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1987 |
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; | 1987 |
The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Tr | 1987 |
Alternating versus sequential therapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1987 |
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Dru | 1988 |
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Clinical | 1986 |
Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclopho | 1986 |
A randomized trial of two regimens of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1986 |
Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclopho | 1986 |
Review of Canadian trials of adjuvant endocrine therapy for breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Canada; Clinical Trials as Topic; Female; Humans; Lymph Nodes | 1986 |
Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Clinical Trials as | 1986 |
Adjuvant therapy of breast cancer: Southwest Oncology Group studies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Clinical Trials as | 1986 |
Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Clinical Tria | 1986 |
Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasms; Clinical Trial | 1986 |
Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Clinical Trials as | 1986 |
Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topi | 1986 |
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bone Neoplasms; Breast Neoplasms; Cispl | 1987 |
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Dru | 1987 |
Age as a prognostic factor in recurrent breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined | 1986 |
Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Fem | 1986 |
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; C | 1986 |
A randomized study of intensive versus moderate chemotherapy programs in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1987 |
A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; F | 1985 |
Adjuvant chemotherapy for operable breast cancer with positive axillary nodes: a comparison of CMFVP versus L-PAM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; Female; | 1985 |
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cyclophosphamide; F | 1985 |
Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1985 |
Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Tr | 1985 |
Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Adjuvant systemic therapy for resectable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 1985 |
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; C | 1985 |
An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Clinical Trials a | 1985 |
Hormono-chemotherapy in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1985 |
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined | 1985 |
Adjuvant treatment in operable breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cy | 1985 |
Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
Topics: Adult; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Com | 1985 |
Systemic adjuvant therapy and breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cost-Ben | 1985 |
[Study of the metastasizing carcinoma of the breast (author's transl)].
Topics: Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Hum | 1973 |
[Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Synergism; | 1973 |
374 other studies available for prednisone and Breast Cancer
| Article | Year |
|---|---|
Primary breast lymphoma - a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 2021 |
A case of bilateral methotrexate-associated diffuse large B-cell lymphomas of the breasts with unique clinical presentation and outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; | 2020 |
ATM mutation in a patient with thymoma-associated myasthenia gravis.
Topics: Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Carcinoma, Ductal, Breast; Cholinesterase | 2020 |
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2021 |
Case 285: Primary Breast Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast; Breast Neoplasms; Cyclophosph | 2021 |
Pyoderma gangrenosum with pathergy: A potentially significant complication following breast reconstruction.
Topics: Adult; Aged; Algorithms; Breast Neoplasms; Cicatrix; Cyclosporine; Debridement; Female; Humans; Immu | 2017 |
[Clinical Efficacy of EPOCH±R Followed by DICE±R Regimen for Primary Breast Diffuse Large B-Cell Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Eto | 2017 |
Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Implantation; Breast Implants | 2018 |
Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast | 2018 |
Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Duc | 2019 |
Chronic eosinophilic pneumonia after trastuzumab and radiation therapy for breast cancer: A case report.
Topics: Administration, Oral; Antineoplastic Agents, Immunological; Breast Neoplasms; Chronic Disease; Femal | 2019 |
Unusual breast neoplasm: primary breast lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 2013 |
Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2014 |
[Le lymphome primitif du sein].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 2014 |
[Clinical and Pathological Analysis of 9 Patients with Primary Breast Diffuse Large B-cell Lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 2015 |
Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea in a Patient with Breast Cancer.
Topics: Aged, 80 and over; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Bronchoscopy; Female; | 2015 |
Secondary Neoplasms in Children with Hodgkin's Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases.
Topics: Adenoma; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Du | 2016 |
Monoallelic germline ATM mutation and organising pneumonia induced by radiation therapy to the breast.
Topics: Adult; Aged; Anti-Inflammatory Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins | 2016 |
Response of extensive breast cancer skin metastases to rechallenge with trastuzumab together with low-dose chemotherapy and insulin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 2016 |
Breast leptomeningeal metastasis recurrence presenting as a manic episode.
Topics: Anti-Inflammatory Agents; Bipolar Disorder; Breast Neoplasms; Female; Humans; Magnetic Resonance Ima | 2017 |
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Topics: Aged, 80 and over; Antibodies, Bispecific; Antineoplastic Agents; Antineoplastic Combined Chemothera | 2016 |
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2017 |
[Granulomatous lobular mastitis: a benign abnormality that mimics malignancy].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Breast Neoplasms; Cytodiagnosis; Diagnosis, Different | 2008 |
Breast lymphoma.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigen | 2008 |
[Prognosis of primary non-Hodgkin's lymphoma of the breast].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bre | 2008 |
New evidence in oncologic and cardiocirculatory medicine.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Boronic A | 2009 |
Early radiation-induced lung injury in a patient with prior diagnosis of bronchiolitis obliterans organizing pneumonitis.
Topics: Anti-Inflammatory Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cryptogenic Organizing Pneumo | 2008 |
B-cell lymphoma of the female breast: comparison of mammography, ultrasound and dynamic MRI.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast; Breast Neoplasms; Cycl | 2010 |
Primary malignant lymphoma of the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diagnosis, Diffe | 2009 |
Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody.
Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplas | 2010 |
Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosph | 2010 |
Pyoderma gangrenosum following bilateral deep inferior epigastric perforator flap breast reconstruction.
Topics: Adult; Biopsy; Breast Neoplasms; Diagnosis, Differential; Epigastric Arteries; Female; Glucocorticoi | 2010 |
Breast lymphoma in Sjögren's syndrome complicated by acute monocular blindness.
Topics: Aged; Blindness; Breast Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Female; Human | 2010 |
[Primary lymphoma of breast: a clinicopathologic, immunophenotypic and prognostic study of 21 cases].
Topics: Adult; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclo | 2010 |
Bilateral primary breast lymphoma masquerading as lactating mastitis.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic | 2010 |
Lymphoma of the breast capsule in a silicone implant-reconstructed patient.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Implantation; Breast Im | 2010 |
Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2011 |
The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast.
Topics: Adult; Aged; Analysis of Variance; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined C | 2012 |
[Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD20; Antineoplastic Combined Chemotherapy Pro | 2011 |
A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy.
Topics: Acute Disease; Breast Neoplasms; Carcinoma, Ductal, Breast; Dose Fractionation, Radiation; Drug Admi | 2011 |
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms | 2012 |
Cardiotoxicity in patients treated with bevacizumab is potentially reversible.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Mono | 2011 |
Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bl | 2012 |
Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous Syste | 2011 |
Metronomic cyclophosphamide and methotrexate for breast cancer: enhanced efficacy by adding dalteparin and low-dose prednisone?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality T | 2011 |
Expect the unexpected: primary breast MALT lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2011 |
Clinical pathologic conference case 1: Wegener's granulomatosis.
Topics: Aged; Anti-Infective Agents; Biopsy; Breast Neoplasms; Cyclophosphamide; Female; Granulomatosis with | 2011 |
[Idiopathic granulomatous mastitis treated with steroids and methotrexate].
Topics: Abscess; Adult; Antitubercular Agents; Breast Neoplasms; Combined Modality Therapy; Dexamethasone; D | 2011 |
Efficacy of the CMFVP regimen in patients with metastatic breast cancer previously treated with anthracycline and taxane.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemo | 2012 |
Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting.
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined C | 2011 |
Electrically active immune-mediated rippling muscle disease preceding breast cancer.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Caveolin 3; Electricity; Electromyography; Female; Hu | 2012 |
Radiation-induced bronchiolitis obliterans organizing pneumonia: a case report and literature review.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Intra | 2012 |
Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 2013 |
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant; | 2003 |
Female patient with a history of Hashimoto's thyroiditis, diagnosed with MALT lymphoma of both breasts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Breast Neoplasms; Cyclophospham | 2003 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Carcinomatous meningitis secondary to breast cancer; polioencephalo-myelitic clinical manifestations; transitory and almost complete regression under the action of delta-cortisone; diffuse carcinomatous invasion of the meninges with exclusion of the pare
Topics: Breast Neoplasms; Humans; Meningeal Carcinomatosis; Meningeal Neoplasms; Meninges; Meningitis; Neopl | 1957 |
Treatment of advanced carcinoma of the breast by bilateral oophorectomy and prednisone.
Topics: Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Ovariectomy; Prednisone | 1960 |
Treatment of advanced carcinoma of the breast by oophorectomy and prednisone.
Topics: Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Ovariectomy; Prednisone | 1960 |
Calcium and phosphate metabolism in disseminated breast cancer: effects of site, progression or regression, and hormonal treatment.
Topics: Androgens; Breast; Breast Neoplasms; Calcium; Calcium, Dietary; Humans; Neoplasms; Phosphates; Predn | 1962 |
[On the treatment of malignant tumors with tris-ethyleneimonobenzoquinone, 19-norandrostenolone decanoate and prednisone].
Topics: Antineoplastic Agents; Breast Neoplasms; Decanoates; Female; Humans; Nandrolone; Nandrolone Decanoat | 1963 |
Adrenal suppression in disseminated carcinoma of the breast. I. The effect on adrenal morphology of hypophysectomy and corticosteroid treatment.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Breast; Breast Neoplasms; Humans; Hydrocortisone; Hypophyse | 1963 |
[Treatment of advanced breast cancer with corticoids].
Topics: Adrenal Cortex Hormones; Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone | 1962 |
[Lost time].
Topics: Breast Neoplasms; Humans; Neoplasm Metastasis; Prednisone | 1962 |
Secondary hormonal therapy of disseminated breast cancer. Comparison of hypophysectomy, replacement therapy, estrogens, and androgens.
Topics: Anatomy; Androgens; Antineoplastic Agents; Biological Therapy; Breast Neoplasms; Estrogens; Fluoxyme | 1963 |
THE OCCURRENCE OF POSTERIOR SUBCAPSULAR CATARACTS IN PATIENTS ON LONG-TERM SYSTEMIC CORTICOSTEROID THERAPY.
Topics: Addison Disease; Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Asthma; Breast Neoplasms | 1963 |
[THE ENDOCRINOLOGICAL PROBLEMS OF HYPOPHYSECTOMY].
Topics: Adenoma; Adenoma, Acidophil; Adenoma, Chromophobe; Adrenocorticotropic Hormone; Breast Neoplasms; Di | 1963 |
CALCIUM AND PHOSPHATE METABOLISM IN PATIENTS WITH DISSEMINATED BREAST CANCER: EFFECT OF ANDROGENS AND OF PREDNISONE.
Topics: Androgens; Blood Chemical Analysis; Bone and Bones; Breast; Breast Neoplasms; Calcium; Calcium, Diet | 1963 |
[HORMONAL THERAPY OF BREAST AND PROSTATIC CARCINOMA].
Topics: Adrenal Cortex Hormones; Adrenalectomy; Androgens; Breast Neoplasms; Castration; Diethylstilbestrol; | 1963 |
TREATMENT OF INOPERABLE CARCINOMA WITH NEWER CHEMOTHERAPEUTIC AGENTS: REPORT OF THREE CASES.
Topics: Bone Neoplasms; Breast Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Prednisone; Retroperito | 1963 |
GLOMERULAR FILTRATION IN DISSEMINATED BREAST CANCER.
Topics: Androgens; Breast Neoplasms; Creatine; Creatinine; Estrogens; Humans; Hydrocortisone; Hypophysectomy | 1964 |
ABDOMINOVAGINAL POTENTIAL DIFFERENCE IN POSTMENOPAUSAL PATIENTS WITH AND WITHOUT BREAST CANCER.
Topics: Abdominal Wall; Adolescent; Androgens; Breast Neoplasms; Castration; Climacteric; Electrophysiology; | 1964 |
SOME UNUSUAL COMPLICATIONS OF METASTATIC CARCINOMA OF THE BREAST.
Topics: Breast Neoplasms; Esophageal Diseases; Esophageal Neoplasms; Esophageal Stenosis; Gastrointestinal H | 1964 |
PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST.
Topics: Androgens; Breast Neoplasms; Castration; Cortisone; Estrogens; Female; Humans; Mastectomy; Menopause | 1964 |
EFFECT OF THERAPY UPON VAGINAL SMEARS IN BREAST CANCER PATIENTS.
Topics: Animals; Biomedical Research; Breast Neoplasms; Diethylstilbestrol; Ethinyl Estradiol; Female; Fluor | 1964 |
ENDOCRINE TREATMENT OF BREAST CANCER.
Topics: Anabolic Agents; Androgens; Breast Neoplasms; Castration; Estrone; Female; Humans; Menopause; Nandro | 1964 |
NONSURGICAL TREATMENT OF PULMONARY CANCER.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen | 1964 |
DETERMINATION OF TESTOSTERONE IN HUMAN PERIPHERAL AND ADRENAL VENOUS PLASMA.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adrenogenital Syndrome; Angiography; Biomedical Researc | 1964 |
[DISCUSSIONS ON MAMMARY CANCER. 4. HORMONAL PALLIATIVE TREATMENT].
Topics: Anabolic Agents; Androgens; Breast; Breast Neoplasms; Castration; Estrogens; Female; Humans; Neoplas | 1963 |
REGRESSION OF METASTATIC HEPATOMEGALY FROM MAMMARY CARCINOMA. CYTOTOXIC COMBINATION CHEMOTHERAPY WITH 5-FU.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Hepatomegaly; Humans; L | 1964 |
MALIGNANT PERICARDIAL EFFUSION. REVIEW OF HOSPITAL EXPERIENCE AND REPORT OF A CASE SUCCESSFULLY TREATED BY TALC POUDRAGE.
Topics: Breast Neoplasms; Cardiac Surgical Procedures; Cardiac Tamponade; Drug Therapy; Exudates and Transud | 1965 |
HYPERCALCEMIA OF BREAST CANCER; MANAGEMENT WITH CORTICOSTEROIDS.
Topics: Adrenal Cortex Hormones; Breast Neoplasms; Calcium; Carcinoma; Drug Therapy; Geriatrics; Humans; Hyp | 1965 |
MICROANGIOPATHIC HEMOLYTIC ANEMIA IN METASTATIC CARCINOMA. REPORT OF A CASE AND BIOCHEMICAL STUDIES.
Topics: Anemia, Hemolytic; Bone Marrow Cells; Breast Neoplasms; Chemical Phenomena; Chemistry; Clinical Enzy | 1965 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 2003 |
Breast cancer after curative chemotherapy in non-Hodgkin's lymphoma: examination of the role of drug resistance and retrospective comparison to the outcome of de novo breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; | 2004 |
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherap | 2004 |
[Clinical and pathological analysis of 15 cases with primary breast lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality The | 2004 |
Primary mammary (non-Hodgkin) lymphoma presenting as locally advanced breast cancer.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2004 |
[Spindle cell variants of diffuse large B cell lymphoma: report of 2 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cyclophosphamide; Diagnosi | 2005 |
Primary breast lymphoma cytologic diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Fine-Needle; Breas | 2005 |
A Case of Burkitt's Lymphoma Involving Both Breasts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophos | 2005 |
Breast lymphoma: favorable prognosis after treatment with standard combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 2006 |
Polymyalgia rheumatica and breast cancer.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Follow-Up Studies; Glucocortico | 2006 |
Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Combined Chemotherapy P | 2006 |
[An unusual breast tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Cyclophosphamide; Doxorubi | 2006 |
A case of bronchiolitis obliterans organising pneumoniae (BOOP) after nine months post-operative irradiation for breast cancer.
Topics: Aged; Breast Neoplasms; Cryptogenic Organizing Pneumonia; Female; Fever; Follow-Up Studies; Humans; | 2008 |
Analysis of differential therapeutic strategies for primary breast lymphoma: two case reports.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antimet | 2009 |
The electroencephalogram in hypercalcemia.
Topics: Adult; Aged; Alkaline Phosphatase; Breast Neoplasms; Diethylstilbestrol; Electroencephalography; Est | 1967 |
The endocrine aspects of trans-sphenoidal hypophysectomy.
Topics: Adrenal Glands; Breast Neoplasms; Cortisone; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans | 1967 |
Hormonal treatment of hypercalcemia caused by bone metastases.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Diethylstilbestrol; Female; Humans; Hypercalcemia; Middle Ag | 1967 |
Chemoendocrine versus endocrine therapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Fluorouracil; Hu | 1984 |
Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, C | 1980 |
[Rare organ manifestation of an immunoblastoma of the breast].
Topics: Bleomycin; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Mammography; M | 1983 |
Aggressive combined modality therapy for advanced local-regional breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiomegaly; Combine | 1984 |
[Individual therapy of the metastatic mammary carcinoma (author's transl)].
Topics: Antineoplastic Agents; Breast Neoplasms; Culture Techniques; Drug Therapy, Combination; Estradiol; F | 1980 |
Fulminant lung metastases from cancer of the breast.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Female; Fluorour | 1981 |
The role of estrogen receptor status in predicting the response of carcinoma of the breast to adjuvant chemotherapy.
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Pap | 1982 |
Steroid-withdrawal radiation pneumonitis in cancer patients.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dexamethas | 1984 |
[Vinblastine, 5-fluorouracil and prednisone (VFP) as "second-line" chemotherapy. Contribution to the problem of optimal therapy sequence in metastasizing breast carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration S | 1983 |
The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arm; Breast Neoplasms; Combined Modality Therapy; Cy | 1983 |
Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmu | 1984 |
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients.
Topics: Adrenal Cortex; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dr | 1980 |
[Simultaneous combined radio-/chemotherapy of locally recurring breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cobalt Radioisotopes; | 1984 |
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carubicin; Cyclophosp | 1984 |
Chemotherapy of advanced breast cancer. A general survey.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Mo | 1984 |
Malignant lymphoma of skin associated with postmastectomy lymphedema.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubici | 1984 |
Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neopla | 1984 |
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclo | 1984 |
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Breast Neoplasms; Cy | 1984 |
[Cytostatic therapy in metastatic breast cancer].
Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 1984 |
Myeloproliferative disorder with profound hypereosinophilia associated with chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Eos | 1984 |
Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modalit | 1984 |
[Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Cyclophosp | 1983 |
Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast | 1983 |
Multimodal therapy in the treatment of breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosph | 1983 |
[Comparative evaluation of the results of mono- and polychemotherapy of disseminated forms of breast cancer using the CMFVP program and anthracycline antibiotics (carminomycin and adriamycin)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carubicin; Cyclophosphamide; Dauno | 1983 |
Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; | 1981 |
Multiple simultaneous and sequential estrogen receptor values in patients with breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosph | 1982 |
VP-16 and adriamycin in patients with advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 1982 |
Primary lymphoblastic lymphoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1982 |
[Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosph | 1982 |
[Malignant tumors in bearers of kidney grafts in immunosuppressive therapy].
Topics: Adult; Antilymphocyte Serum; Azathioprine; Breast Neoplasms; Dysgerminoma; Female; Humans; Immunosup | 1982 |
Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
Topics: Adult; Aged; Aminoacridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1982 |
[Combination of three therapy methods (operation-radiotherapy-chemotherapy) in case of mammary carcinoma with lymph node metastases].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; | 1982 |
[Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen].
Topics: Aged; Breast Neoplasms; Castration; Diethylstilbestrol; Humans; Male; Middle Aged; Prednisone; Tamox | 1982 |
A five-drug combination in the treatment of metastatic breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; | 1981 |
[Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1981 |
[Results of, and indications for adjuvant chemotherapy in breast cancer].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; | 1981 |
Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; F | 1980 |
[Results of "5-drug" treatment of advanced breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1981 |
Is there a place for adjuvant endocrine therapy of breast cancer?
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Castration; Drug Therapy, Combination; Female; Human | 1980 |
Response of a choroidal metastasis to multiple-drug chemotherapy.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Choroid Neoplasms; Cyclophosphamide; Drug Therapy, C | 1980 |
The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cyclophosphami | 1980 |
Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1980 |
Management of locally advanced and disseminated breast cancer--chemotherapy.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agen | 1980 |
Modern approaches to the treatment of breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menstru | 1980 |
Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience.
Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Pre | 1980 |
Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; | 1981 |
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
Topics: Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cel | 1993 |
[Breast cancer after treatment of Hodgkin's disease].
Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 1995 |
Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Forced Expirato | 1995 |
Tandem transplants in solid tumors: marrow versus peripheral stem cell transplant: peripheral blood cells as now practiced are not the whole answer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow Transplantation; Breas | 1993 |
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1994 |
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.
Topics: Breast Neoplasms; Fatal Outcome; Female; Gene Expression Regulation, Viral; Glomerulonephritis, Memb | 1993 |
[Primary breast lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; C | 1993 |
Breast cancer developing after therapy for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr | 1993 |
Factors influencing aromatase activity in the breast.
Topics: Adipose Tissue; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast | 1993 |
Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms | 1993 |
Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancer.
Topics: Aged; Autoantibodies; Breast Neoplasms; Diagnosis, Differential; Factor VIII; Female; Hematoma; Huma | 1995 |
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alky | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alky | 1996 |
Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoi | 1996 |
Low-dose prednisone and increased risk of development of bone metastases.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bon | 1996 |
[Bilateral highly malignant centroblastic lymphoma of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Doxor | 1996 |
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 1997 |
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1997 |
Primary non-Hodgkin's lymphoma of the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 1998 |
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 1998 |
[Urinary enzymes during some antiblastic chemotherapy protocols].
Topics: alpha-Glucosidases; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers | 1983 |
Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P)
Topics: Aged; Anti-Inflammatory Agents; Breast Neoplasms; Bronchoalveolar Lavage Fluid; Carcinoma; Chemother | 1998 |
Multiple myeloma in the breast.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Doxorubicin; Fatal | 1999 |
High grade MALT-lymphoma of the breast.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Cyclophos | 1999 |
[Relapsing paraneoplastic cerebellar syndrome and limbic encephalitis in a patient with breast cancer].
Topics: Anti-Inflammatory Agents; Autoantibodies; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagn | 2000 |
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 2000 |
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemot | 2000 |
Gallium-67 scintigraphic findings in a patient with breast lymphoma complicated with Sjögren syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubic | 2000 |
Large B-cell lymphoma of thyroid. Two cases with a marginal zone distribution of the neoplastic cells.
Topics: Adenocarcinoma; Aged; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplas | 2000 |
Treatment of prognosis of primary breast lymphoma: a review of 13 cases.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormona | 2000 |
[Diagnostic problems due to alternative medicine].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N | 2000 |
Effect of systemic lupus erythematosus (SLE) treatment drugs on GI-101A breast tumor cell growth.
Topics: Breast Neoplasms; Enzyme Activation; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lupus Erythemato | 2000 |
Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity.
Topics: Adult; Aged; Anti-Inflammatory Agents; Breast Neoplasms; Cryptogenic Organizing Pneumonia; Eosinophi | 2000 |
Sample size calculations for the two-sample problem using the multiplicative intensity model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Child; Cyclophosphamide; Disease-F | 2001 |
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Com | 2001 |
Mantle cell lymphoma presenting as a breast mass.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 11; Chrom | 2001 |
Primary breast lymphoma: a report of 20 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dis | 2001 |
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2002 |
gamma/delta peripheral T-cell lymphoma of the breast diagnosed by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosph | 2002 |
Modification of HLA antigens in patients with malignancies following hormone therapy.
Topics: Breast Neoplasms; Diethylstilbestrol; Drug Therapy, Combination; Epitopes; Female; HLA Antigens; Hum | 1978 |
Ovarian function and adjuvant chemotherapy for breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Melphala | 1978 |
[Chemotherapy of malignant skeletal tumors (author's transl)].
Topics: Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Humans; Lymphoma; Melphalan; Multiple Myeloma; N | 1979 |
[Confluent pulmonary deposits from carcinoma of the breast under cytostatic therapy (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Female; H | 1976 |
[Hypercalcemia therapy in malignant tumors].
Topics: Breast Neoplasms; Calcitonin; Female; Fluid Therapy; Humans; Hypercalcemia; Male; Neoplasms; Phospha | 1979 |
[Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Car | 1976 |
[After care of breast carcinoma].
Topics: Aftercare; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Predn | 1976 |
Mastectomy as an adjunct to combination chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Int | 1978 |
Leucovorin in combination chemotherapy of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Le | 1977 |
Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; Femal | 1978 |
Chemotherapy for breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; F | 1979 |
[The period of time between operation and irradiation of a mamma carcinoma and its cytostatic treatment (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; | 1979 |
[Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therap | 1979 |
Treatment and survival in advanced breast cancer.
Topics: Breast Neoplasms; Estradiol Congeners; Female; Humans; Neoplasm Metastasis; Prednisone; Research Des | 1979 |
Adjuvant therapy for carcinoma of the breast.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Ovary; Prednisone | 1979 |
5-drug adjuvant chemotherapy for breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluoro | 1979 |
Potentiating role of previously administered agents in the combination chemotherapy of breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Synergism; Drug Therapy, Comb | 1979 |
Adjuvant chemotherapy of breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1979 |
[Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Evaluation Studies a | 1979 |
A well tolerated oral combination of chlorambucil (Leukeran R), methotrexate, fluorouracil, prednisone (LMFP) in disseminated breast cancer.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; | 1979 |
Sequence for developing optimal combination chemotherapy of metastatic breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotr | 1979 |
Management of non-resectable (stage III) breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Drug Therap | 1979 |
Clinical trial of nafoxidine in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Mid | 1978 |
[Polychemotherapy of advanced cancer of the breast].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans | 1978 |
Treatment of hepatic metastases from breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1978 |
Corticosteroids in radiation-induced pericarditis.
Topics: Acute Disease; Breast Neoplasms; Female; Humans; Middle Aged; Pericardial Effusion; Pericarditis; Pl | 1978 |
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
Topics: Adult; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Ovary; Predni | 1978 |
Systemic therapy for metastatic breast cancer.
Topics: BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Estrogens; Female; Fluor | 1977 |
Dermatomyositis and Malignancy.
Topics: Breast Neoplasms; Dermatomyositis; Female; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Pr | 1977 |
Adjuvant treatment of cancer. II. Breast carcinoma.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; F | 1977 |
Therapy of primary breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Lymphatic Metasta | 1977 |
Therapy of advanced breast cancer.
Topics: Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluo | 1977 |
[Cytostatic pneumopathy following chemotherapy for metastasizing breast neoplasm].
Topics: Aged; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Ethinyl Estradiol; Female; Femo | 1977 |
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combinatio | 1977 |
Outpatient chemotherapy of advanced breast cancer in a community setting: a five-drug regimen.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therap | 1976 |
[Experiences with cytostatic treatment of malignant tumors].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cyclophos | 1976 |
[Preliminary experiences in the treatment of metastatic mamma carcinoma by polychemotherapy-according to Cooper (author's transl)].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Combinations; Drug Therapy, Combination; Female; Fluorourac | 1976 |
Combination chemotherapy in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Co | 1976 |
Combination chemotherapy for disseminated carcinoma of the breast.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Com | 1975 |
Impaired lymphocyte responses to PPD-tuberculin in advanced breast carcinoma. Increased reactivity after depletion of phagocytic or adherent cells.
Topics: Androgens; B-Lymphocytes; Breast Neoplasms; Cell Aggregation; DNA Replication; Female; Humans; Lecti | 1976 |
Chemotherapy of breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Hu | 1975 |
Letter: Combination chemotherapy for breast cancer.
Topics: Bone Marrow; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Hu | 1975 |
[Letter: Prednisone in combination therapy of breast cancer].
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Prednisone | 1975 |
Hyperlucent lung after radiation therapy.
Topics: Angiography; Bone Neoplasms; Breast Neoplasms; Chlorambucil; Dyspnea, Paroxysmal; Female; Humans; Lu | 1975 |
Chemotherapy in the treatment strategy of breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Hu | 1975 |
A controlled study in the use of combined drug therapy for metastatic breast cancer.
Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Drug Therapy, | 1975 |
An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Cyclophosphamide; Doxorubic | 1975 |
[Cell cycle and carcinochemotherapy: reality or hope? (author's transl)].
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cyclophosphamide; Drug Therapy, Combination; | 1975 |
Editorial: Major advance in breast-cancer therapy.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil | 1976 |
Combination chemotherapy for advanced breast cancer: response and effect on survival.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Li | 1976 |
Orofacial complications of chemotherapy for breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Candidiasis, Oral; Chi-Squa | 1992 |
Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Fem | 1992 |
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Fem | 1992 |
Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combi | 1992 |
Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therap | 1992 |
Bilateral breast involvement in a 71-year-old white man with lambda light chain disease. Regression after a new chemotherapy combination. A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Humans; Immun | 1992 |
Preoperative chemotherapy in primarily inoperable cancer of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1991 |
A reexamination of the relationship between myositis and malignancy.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Male; Mid | 1991 |
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplas | 1991 |
Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfa | 1990 |
Predictors of physician nonadherence to chemotherapy regimens.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Attitude of Health Personnel; Breast Ne | 1991 |
Weight gain with breast cancer adjuvant treatment.
Topics: Adaptation, Psychological; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl | 1991 |
Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1991 |
Breast cancer staging and the "alert": an educational dilemma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Communi | 1990 |
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined M | 1990 |
Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: implications for improved cure rates in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administrat | 1990 |
Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dru | 1990 |
Adjuvant chemotherapy and scar irradiation in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1990 |
Short term high density systemic therapy for metastatic breast cancer.
Topics: Altretamine; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Combined Modality Therapy; Doxorubi | 1985 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, | 1985 |
[Treatment of metastatic breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacar | 1986 |
Multimodal treatment for inflammatory breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined M | 1989 |
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Breast Neoplasms; | 1989 |
[Radiotherapy with neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub | 1989 |
[Bone marrow necrosis in a patient with metastatic breast cancer in chemotherapy with chlorambucil, methotrexate and prednisone].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neopl | 1989 |
[A carcinoma of the right breast arising after a mastectomy in primary malignant lymphoma of the left breast].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combine | 1989 |
The role of chemotherapy for node negative breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; | 1989 |
[The effect of chemotherapy on survival time in advanced breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Mo | 1989 |
Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Dose- | 1989 |
Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cycloph | 1989 |
Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Breast Neoplasms; Cholestasis, Intr | 1989 |
Side effects and emotional distress during cancer chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxor | 1989 |
Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Factors; Breast Neoplasms; Cycloph | 1989 |
Yellow nail syndrome.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Lymphedema; Middle Aged; | 1986 |
Further study of five-drug combined chemotherapy for advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1986 |
Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Breast Neoplasms; Cobalt Radioisotope | 1988 |
Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphami | 1988 |
Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Daunorubicin; Dr | 1988 |
[Long-term survival of two patients with Burkitt's lymphoma treated by surgical resection and intensive chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cecal Neo | 1988 |
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Hodgkin | 1988 |
Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1988 |
Weight gain in women with localized breast cancer--a descriptive study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined Modal | 1988 |
Primary chemotherapy with mitoxantrone and prednisone in advanced breast carcinoma. A phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Hu | 1988 |
Adjuvant chemotherapy for breast cancer: 20 years experience using CVFMP chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Anti | 1988 |
[Second tumors in patients treated for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali | 1988 |
[Granulocytic sarcoma (chloroma) with bladder and breast localizations preceding acute myeloblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug | 1987 |
Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combi | 1987 |
Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hodgkin Disease; Hu | 1987 |
Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Flu | 1987 |
Preoperative chemotherapy for fungating breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Met | 1987 |
Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer.
Topics: Activities of Daily Living; Adult; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Brea | 1986 |
Chemotherapy induces regression of brain metastases in breast carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Brain Neoplasms; Breast Neopla | 1986 |
The problem of local control in patients with advance breast cancer--a combined modality approach.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1986 |
Intestinal cryptosporidiosis: a complication of cancer treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Combin | 1986 |
Assessment of adjuvant trials in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To | 1986 |
Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Breast Neo | 1986 |
On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1986 |
Case 6-1985: progressive pneumonitis after chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour | 1985 |
Chemohormonal therapy and endocrine function in breast cancer patients.
Topics: Adult; Amenorrhea; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cycl | 1985 |
Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Combined | 1985 |
The use of adjuvant chemotherapy for breast cancer in a community practice.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; | 1985 |
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neopla | 1985 |
[Cardiotoxic effect of cytostatics in patients with breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Flu | 1985 |
[Cytostatic polychemotherapy in the aged].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dac | 1985 |
Rationale for combining chemotherapy and hormonal therapy in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosph | 1985 |
Combination chemotherapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1985 |
Multiple myeloma masquerading as metastatic breast cancer.
Topics: Agammaglobulinemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasm | 1986 |
[Chemotherapy for recurrent breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Dru | 1985 |
Weight gain during adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Body Weight; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Melphala | 1985 |
Radiation pneumonitis: a complication resulting from combined radiation and chemotherapy for early breast cancer.
Topics: Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Middle Aged; Pneumonia; Pred | 1985 |
Systemic chemotherapy of mammary carcinoma.
Topics: Amines; Antineoplastic Agents; Azirines; Azo Compounds; Breast Neoplasms; Caproates; Carbohydrates; | 1971 |
Current concepts in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Adult; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Fluorouracil; Huma | 1972 |
Palliative treatment of mammary cancer. Response of soft tissue, pleural and pulmonary disease.
Topics: Adrenalectomy; Adult; Age Factors; Aged; Breast Neoplasms; Castration; Cyclophosphamide; Dexamethaso | 1973 |
Treatment of dermatomyositis with methotrexate.
Topics: Adrenal Cortex Hormones; Adult; Aged; Breast Neoplasms; Carcinoma; Dermatomyositis; Female; Humans; | 1968 |
Disseminated toxoplasmosis in the compromised host. A report of five cases.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Autopsy; Azathioprine; Brain; Breast Neoplasms; Female; | 1974 |
Hypercalcemia complicating breast cancer. Clinical features and management.
Topics: Adrenalectomy; Bone Neoplasms; Breast Neoplasms; Diet Therapy; Female; Humans; Hydrocortisone; Hyper | 1973 |
[Therapeutic possibilities in metastatic cancer of the breast with hypercalcaemia. (Apropos of 2 cases)].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Bone Neoplasms; Breast Neoplasms; Castration; Cyc | 1969 |
Resolution of chronic eosinophilic pneumonia with corticoid therapy. Demonstration by needle biopsy.
Topics: Adult; Biopsy; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Lung; Meth | 1971 |
Pemphigus vulgaris and internal malignancy.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Dexamethasone; F | 1974 |
Pseudomonas blepharoconjunctivitis: a complication of combination chemotherapy.
Topics: Antineoplastic Agents; Bacitracin; Blepharitis; Bone Marrow; Breast Neoplasms; Carbenicillin; Cephal | 1974 |
Clinical significance of estrogen receptors in human breast cancer.
Topics: Adrenalectomy; Animals; Breast; Breast Neoplasms; Castration; Cell Nucleus; Cytosol; Estradiol; Estr | 1974 |
[Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Castration; Cyclophosphamide; Drug Therapy, Comb | 1974 |
[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; Drug Synergism; F | 1972 |
Positive gallium 677 photoscan in myeloblastoma.
Topics: Adolescent; Adult; Breast Neoplasms; Citrates; Female; Gallium; Humans; Leukemia, Myeloid, Acute; Me | 1972 |
Acute leukemia complicating metastatic breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Female; Fluorouracil | 1973 |
Combination chemotherapy in disseminated carcinoma of the breast.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Evaluation Stu | 1974 |
[Theory and practice of systemic cancer therapy].
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cyclophosphamide; Family Practice; Female; H | 1972 |
Five-drug combination chemotherapy for disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Drug | 1972 |
[On the use of isotope hypophysectomy with yttrium 90 in mammary neoplasms].
Topics: Breast Neoplasms; Cortisone; Humans; Mastectomy; Neoplasm Metastasis; Pituitary Irradiation; Postope | 1973 |
Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinoma.
Topics: Adenocarcinoma; Adrenalectomy; Adult; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Huma | 1973 |
Secondary chemotherapy of advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chlorambucil; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm M | 1973 |
Cecal necrosis and perforation with systemic chemotherapy.
Topics: Adult; Asparaginase; Breast Neoplasms; Cecal Diseases; Child; Cytarabine; Daunorubicin; Female; Fluo | 1973 |
[Iatrogenic diabetic coma. Contribution to adverse effects of cytostatic therapy].
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Diabetic Coma; Female; Fluorouracil; Huma | 1973 |
[Significance of ( 85 Sr) radioisotope bone scanning in the early diagnosis of bone metastases and possibilities of their therapy].
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Castration; Cobalt Isotopes; Female; | 1973 |
Combination chemotherapy in disseminated carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Synergism; Female; Fluorouracil; Humans; Metho | 1973 |
Thrombocytopenia from metastatic carcinoma of the breast. Effective managements of patients with this complication.
Topics: Adrenalectomy; Aged; Blood Cell Count; Blood Platelets; Bone Marrow; Bone Neoplasms; Breast Neoplasm | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cyt | 1973 |
Disseminated breast carcinoma. Treatment with combination chemotherapy.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Fem | 1973 |
[Cytostatic combination therapy in metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; F | 1973 |
[Castration and chemotherapy as a part of the primary surgical treatment of breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Female; Humans; Middle Aged; Posto | 1973 |
[Cooper's combination chemotherapy of metastasizing breast carcinoms].
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Methotrexate; Middle | 1973 |
An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Breast Neoplasms; Cyclophosphamide; Drug Therap | 1974 |
A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
Topics: Alopecia; Blood Platelets; Breast Neoplasms; Castration; Cyclohexanes; Cyclophosphamide; Drug Evalua | 1974 |
Cyclical combination chemotherapy for advanced breast carcinoma.
Topics: Adrenalectomy; Adult; Alopecia; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Castration; Cyclophos | 1974 |
[Carcinoma of the male breast].
Topics: Breast Neoplasms; Carcinoma; False Negative Reactions; Humans; Male; Mastectomy; Middle Aged; Neopla | 1974 |
Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.
Topics: Adrenalectomy; Adult; Aged; Breast Neoplasms; Carcinoembryonic Antigen; Castration; Cyclophosphamide | 1974 |
[Letter: Prednisone treatment of breast cancer with metastases].
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma; Female; Femoral Neoplasms; Humans; Neoplas | 1974 |
Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
Topics: Administration, Oral; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug The | 1974 |
Fluoride therapy for pain in malignant bone disease.
Topics: Adult; Aged; Analgesia; Bone Neoplasms; Breast Neoplasms; Estrogens; Fluorides; Fluoxymesterone; Hum | 1968 |
[Treatment of advanced cancer of the breast].
Topics: Breast Neoplasms; Female; Humans; Prednisone; Time Factors | 1972 |
Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
Topics: Administration, Oral; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carmustine; Female | 1972 |
Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Topics: Adrenalectomy; Adult; Aged; Alopecia; Ataxia; Blood Platelet Disorders; Breast Neoplasms; Diarrhea; | 1972 |
The phase II study: some reflections, particularly concerning disseminated breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Cyclohexanes; Cyclophosphamide; Female; Fluorou | 1972 |
Chemotherapy of breast carcinoma.
Topics: Adult; Amines; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; Humans; Imida | 1972 |
Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; Co | 1971 |
Five-drug therapy for advanced breast cancer: a phase I study.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans | 1971 |
[Breast neoplasms].
Topics: Adrenalectomy; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Hypophysectomy; Mastectomy; P | 1971 |
[Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
Topics: Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Gastrointestinal Ne | 1969 |
Evaluation of adrenalectomy and hypophysectomy in the treatment of metastatic cancer of the breast.
Topics: Adrenalectomy; Breast Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Hypophysectomy; Ne | 1969 |
Combined chemotherapy of epithelial tumours.
Topics: Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Dactinomycin; DNA, Neoplasm; Female; Humans; Ma | 1970 |
[Breast neoplasms, endocrine treatment and chemotherapy].
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Middle Aged; Ovary; P | 1970 |
Hypercalcemia associated with neoplastic disease.
Topics: Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Dactinomycin; Electrocar | 1970 |
Metastatic calcification of the myocardium.
Topics: Adult; Autopsy; Breast Neoplasms; Calcinosis; Carcinoma; Cardiomyopathies; Female; Fluoxymesterone; | 1970 |
Treatment of advanced cancer of the breast with 5-fluorouracil.
Topics: Adult; Aged; Breast Neoplasms; Castration; Cobalt Isotopes; Female; Fluorouracil; Humans; Mastectomy | 1971 |
[Erysipelatoid, angiectasic cancer of the breast. Mode of development].
Topics: Breast Neoplasms; Carcinoma; Cyclophosphamide; Female; Humans; Lymphedema; Middle Aged; Neoplasm Rec | 1967 |
[The present position of hormone treatment of metastasizing cancer diseases].
Topics: Breast Neoplasms; Estrogens; Female; Gonadal Steroid Hormones; Humans; Male; Neoplasm Metastasis; Pr | 1967 |
Urinary steroid values as a guide to prognosis in breast cancer.
Topics: 17-Hydroxycorticosteroids; Adult; Age Factors; Aged; Androgens; Breast Neoplasms; Cyclophosphamide; | 1968 |
Effects of cortisol deficiency on the electrocardiogram.
Topics: Breast Neoplasms; Electrocardiography; Endocrine System Diseases; Female; Humans; Hydrocortisone; Hy | 1968 |
A radioisotopic method for determining optimum non-surgical therapy for advanced cancer. II. Clinical experience.
Topics: Adenocarcinoma; Breast Neoplasms; Diethylstilbestrol; Female; Fluorouracil; Fluoxymesterone; Gastroi | 1968 |
Effect of artificially induced abacterial erysipelas and of chronic aseptic abscess on human and experimental neoplasms.
Topics: Abscess; Adult; Aged; Amylases; Anemia; Animals; Breast Neoplasms; Child; Erysipelas; Eye Neoplasms; | 1968 |
Treatment of metastatic carcinoma of the female breast with combination of hormones and other chemotherapy.
Topics: Breast Neoplasms; Cyclophosphamide; Diethylstilbestrol; Female; Fluorouracil; Humans; Neoplasm Metas | 1968 |
Hormonal therapy of cancer of the female breast.
Topics: Androgens; Breast Neoplasms; Carcinoma; Diethylstilbestrol; Estrogens; Ethinyl Estradiol; Female; Ho | 1969 |
Hormone therapy in metastatic breast cancer: clinical response and urinary gonadotrophins.
Topics: Aged; Anabolic Agents; Breast Neoplasms; Diethylstilbestrol; Female; Gonadotropins; Humans; Neoplasm | 1965 |
[Chemotherapy of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Prednisone | 1965 |
Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Calcium; Estradiol; Female; Humans; Hypercalcemia; Middle A | 1966 |
[Conservative hormonal treatment of metastatic mammary cancer].
Topics: Breast Neoplasms; Estrogens; Female; Humans; Nandrolone; Neoplasm Metastasis; Ovary; Prednisone; Rad | 1966 |
[Hair melanogenesis in endoxan alopecia and its modification by corticosteroids].
Topics: Alopecia; Breast Neoplasms; Cyclophosphamide; Female; Hair; Humans; Male; Melanins; Neoplasms; Predn | 1966 |